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Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive form of inherited 
heart muscle disease characterized by ventricular arrhythmias and sudden cardiac death. Often 
the pathogenesis is linked to deleterious mutations in the desmosomal gene plakophilin-2 
(PKP2). We extended investigations of the pathogenic PKP2 c.1162C>T founder mutation 
which had previously been reported to occur within four ‘unrelated’ probands (6.2%) who self-
identified as Afrikaners and who also carried a common haplotype. Common evolutionary 
history suggests common haplotypes are linked to a common founder and today the Afrikaner 
populations are a unique ethnic group in South Africa identified with various founder effects 
for a range of heritable disorders.  
Aim 
This study aimed to identify the common founder using genealogical and molecular methods 
for the PKP2 c.1162C>T mutation in ARVC families of Afrikaner descent in South Africa. 
Methods and results 
DNA was collected from 46 participants (7 probands and 39 relatives) from the ARVC Registry 
of South Africa. Probands and relatives were screened for the PKP2 c.1162C>T mutation using 
High Resolution Melt and Sanger sequencing. The genetic results indicated that 65.2% (30/46) 
of the family members harbored this mutation. High Resolution Melt, Sanger sequencing and 
microsatellite typing were used to create a haplotype which encompassed the c.1162C>T 
mutation and three microsatellite markers (M1, D12S1692 and M2) spanning the PKP2 gene. 
A common haplotype emerged that segregated amongst all of the affected members of the 
seven Afrikaner families. 
Genealogical tracing went back, through multiple generations, into the implicated ancestral 
lines of the present day Afrikaner families. Four of the seven families attained their 17th century 
progenitors. Through genealogical analyses of the two largest families, ACM 19 and ACM 38, 
we identified 116 couples which we reduced to ten candidate South African founder couples 
who were then subjected to further analyses. After the ACM 12 family was added to the 
analysis there were five candidate founder couples. Unfortunately, the ACM 71 family did not 
progress past the 20th century due to tracing difficulties associated with poor record keeping of 
mixed ancestry data in South Africa and hence, could not be linked back to any other family 
11 
tree without finding ACM71.5’s grandparents. Additionally, ACM 8 and 57 families were 
recent finds and completion of their genealogical tracing still has to done. 
Conclusions 
Our genetic data showed that not only were 30/46 individuals positive for the PKP2 c.1162C>T 
mutation but that all 30 individuals also shared the same common haplotype.  Our preliminary 
genealogy tracing data suggests that the PKP2 c.1162C>T mutation segregates at a higher 
frequency in the Afrikaner population possibly due to a founder effect. The genealogical 
evidence supports the hypothesis that the PKP2 c.1162C>T mutation is a founder mutation and 
that descendants of the common founders are at risk of developing ARVC.  At least three more 
families need to be recruited to make a clear conclusion and achieve genealogical evidence 
based saturation, ideally, a common founder.  
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Arrhythmia: a condition in which the heart beats with an irregular or abnormal rhythm (NIH, 
2011). 
Autosome: any of the 22 chromosomes exclusive of the sex chromosomes, X and Y (Strachan 
and Read, 1999).  
Cardiomyopathy: a myocardial disorder that has an abnormal structure and function in heart 
muscle, in the absence of congenital heart disease, coronary artery disease, hypertension and 
valvular disease sufficient to cause the observed myocardial abnormality (Elliott et al., 2008). 
Compound heterozygote:  a genotype with two different mutant alleles at the same locus 
(Nussbaum et al., 2015). 
Desmosomes: intercellular junctions that provide strong adhesion between cells (Garrod and 
Chidgey, 2008). 
Dominant: a human genetics term used for a trait conveyed in a heterozygote (Strachan and 
Read, 1999). 
Double heterozygote: individual, or genotype, with two different mutant alleles, each one at 
different loci. Not to be confused with compound heterozygote (Nussbaum et al., 2015). 
Edict of Fontainebleau (1685):  was a decree issued by Louis XIV of France, also known as 
the ‘Revocation of the Edict of Nantes’. It banned Protestant worship and the emigration of 
Protestants (Mostert, 2013).  
Edict of Nantes (1598): a decree that granted the Huguenots the right to practice their religion 
without persecution from the state by King Henry IV of France (Mostert, 2013). 
Gene: a functional DNA unit regulating phenotype which segregates in pedigrees according to 
Mendelian laws (Strachan and Read, 1999). 
Heart Failure: this is clinical syndrome which is characterized by effort intolerance and fluid 
retention due to cardiac dysfunction (Ntusi and Mayosi, 2009). 
Homozygote: a genotype in which the two mutant alleles are identical (Nussbaum et al., 2015). 
Huguenots: Calvinist Protestants of France (Mostert, 2013). 
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Implantable cardioverter defibrillator (ICD): a surgically inserted medical device used for 
therapy. It shocks the heart when it develops a tachyarrhythmia such as ventricular tachycardia 
or ventricular fibrillation (Haluska et al., 1989). 
Microsatellite: a polymorphic locus consisting of a variable number of tandemly repeated 
dinucleotide, trinucleotide or tetranucleotide units such as (TG) n, (CAA) n, or (GATA) n; 
different number of units constitute the different alleles. Often termed ‘microsatellite marker’ 
and are used for DNA profiling for kinship. See Single tandem repeat polymorphism (STRP) 
(Nussbaum et al., 2015). 
Mutation: any permanent alteration in genomic DNA that can is heritable. Often leading to a 
variant, an allele differing from the wildtype (Nussbaum et al., 2015). 
Penetrance: the fraction of individuals with a genotype known to cause a disease, with any 
signs and symptoms of the disease (Nussbaum et al., 2015). 
Progenitor: is a direct ancestor. For example, your father's father is your progenitor. Your 
father's father's brother is not your progenitor. In this study, a progenitor often refers to the 
original immigrant of a family to arrive in present day South Africa (Cardinal, 2004).  
Single nucleotide polymorphisms (SNPs): a change in DNA at a single base pair in DNA that 
occurs at a frequency of ≥1% in the general population. (Stenson et al., 2009, Nussbaum et al., 
2015). 
Single tandem repeat polymorphism (STRP): see Microsatellite. 
Sudden cardiac death: a sudden death that is thought to be due to a cardiac cause (Chin, 
2015). 
Syncope: a transient, self-limited loss of consciousness with an inability to maintain postural 
tone that is followed by spontaneous recovery. This definition excludes seizures, coma, shock, 






Cardiovascular diseases are  the leading cause of mortality in the world  (Roth et al., 2015). In 
Sub-Saharan Africa, up to 30% of acute heart failure hospitalizations and early mortality are 
associated with cardiomyopathies (Sliwa et al., 2005). Cardiomyopathy is a myocardial 
disorder that is characterized by an abnormal structure and function of the heart muscle, in the 
absence of congenital heart disease, coronary artery disease, hypertension and valvular disease 
sufficient to cause the observed myocardial abnormality (Elliott, Andersson et al. 2008). The 
disease has several known forms, namely arrhythmogenic right ventricular cardiomyopathy 
(ARVC), dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM) and 
peripartum cardiomyopathy (PCM) (Chin, 2015). Due to the establishment of ARVC registries 
and advancements in genetic research over the last 20 years, more cases have been observed 
and knowledge and awareness gradually expanded (Hendricks et al., 2010). We focused 
primarily on ARVC and its genetic and genealogical links to the founder mutation.  
 
7.2 Natural history of ARVC 
The earliest documented account of modern day ARVC is believed to be as far back in records 
as 1736, documented by the Pope’s physician, Giovanni Maria Lancisi, in his book entitled 
“De Motu Cordis et Aneurysmatibus” (Romero et al., 2013). ARVC accounts were also 
reported in 1977, during surgery to map and treat ventricular tachycardia at the Hôpital de La 
Salpêtrière, when the disease was first termed ‘arrhythmogenic right ventricular dysplasia’ 
(ARVD) (Fontaine and Chen, 2014). Furthermore, in the late 1980s through autopsy studies, 
Thiene et al (1988) discovered that ARVC was a major cause of sudden death in the young 
(<35 years) and in competitive athletes (Turrini et al., 2001, Marcus et al., 2010, Thiene et al., 
1988). As a result in 1982, the first comprehensive clinical profile was developed (Turrini et 
al., 2001). This led to ARVC being included, for the first time,  in the World Health 
Organization (WHO) classification of cardiomyopathies (Fontaine and Prost-Squarcioni, 
2004).  
Estimating the prevalence of ARVC in the general population is difficult due to the challenging 
nature of the diagnosis. In European studies, a prevalence of between 0.6 and 4.4 per 1000 has 
been reported (Quarta and Elliott, 2012).  Investigations into the incidence and prevalence of 
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ARVC have not yet been conducted in African populations (Alfieri et al., 2014). A prevalence 
of 1:1000 to 1:5000 has been estimated in Europe and the US (McNally et al., 2014). 
 
7.3 Phenotype of ARVC 
Arrhythmogenic right ventricular cardiomyopathy is a type of heart muscle disease 
(cardiomyopathy) characterized by progressive fibro-fatty replacement of the ventricular 
myocardium (Basso et al., 2008). This causes the walls of the heart chamber to become thin 
and dilated either focally (i.e., aneurysm) or globally (Figure 1), leading to right ventricular 
dysfunction and cardiac arrhythmias. It is classically described as a disease of the right ventricle 
(RV), but left ventricular (LV) involvement is increasingly recognized (Asimaki and Saffitz, 
2011, Wilde and Behr, 2013). ARVC often presents with palpitations, syncope, heart failure 
and sudden cardiac death (SCD) (Teo et al., 2015, Cahill et al., 2013).  
 
Figure 1: Variations between a normal heart (left) and an ARVC affected heart (right), with right-sided ventricle 
involvement only (circled). 
(Adapted and modified from (Wilde and Behr, 2013)).  
 
This disorder is asymptomatic in 40% of the affected, familial in over 50% of cases (Sen-
Chowdhry et al., 2010) and currently has no cure.  Its complexity lies in it being autosomal 
dominant with many patients carrying mutations in more than one disease gene region (double 
or compound heterozygosity) (Watkins et al., 2009). Penetrance, which is age dependent as in 
other cardiomyopathies, is reduced; it is also thought to be uncommon to find large extended 
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families with ARVC, and so far, the yield of clinically affected cases through family cascade 
screening has been limited (Cahill et al., 2013, Quarta and Elliott, 2012, Elliott et al., 2008). 
 
Generally, definitive identification of the diseased phenotype is challenging (Quarta and Elliott, 
2012). This is partially due to the “concealed” phase which typically precedes overt 
cardiomyopathy, the development of heart failure in 10-20% of the cases, and the rare 
presentation of ventricular systolic dysfunction (Cahill et al., 2013, Elliott et al., 2008). 
Furthermore, young and active probands often first manifest the disease via a malignant 
arrhythmia that often causes SCD; hence, most families are screened and recruited after the 
SCD of a relative (Marcus et al., 2010). 
 
Arrhythmogenic right ventricular cardiomyopathy may be aggravated by endurance exercise, 
which can lead to SCD. Hence, ARVC has forced some athletes to retire young such as Fabrice 
Muamba (2012) and James Taylor (2016), or risk joining the unfortunate athletes who died 
whilst playing for their teams, namely, Antonio Puerta (2007), Matt Gadsby (2009), and Kirk 
Urso (2012) (Amofa, 2016). 
 
The diagnosis of ARVC is based on the presence of criteria that include structural, histological, 
electrocardiographic, arrhythmic and genetic factors that are characteristic of the disease 
(McKenna et al., 1994). These criteria are divided into major and minor criteria, based on their 
specificity for ARVC. An initial set of task force criteria was presented in 1994 by McKenna 
and colleagues, and a revision of these criteria was proposed by Marcus and colleagues in 2010 
(Appendix 1). 
 
7.4 Genetics of ARVC 
Arrhythmogenic right ventricular cardiomyopathy is mostly associated with five desmosomal 
genes (Figure 2) i.e. desmocollin-2 (DSC2), desmoglein-2 (DSG2), junctional plakoglobin 
(JUP), plakophilin-2 (PKP2) and desmoplakin (DSP).  The PKP2 gene is the most common 
genetic cause of ARVC (Alcalde et al., 2014, Watkins et al., 2009), accounting for up to 70% 
of mutation-positive cases found in European populations (te Riele et al., 2014, te Riele et al., 
2012) .    
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Figure 2: The cardiac desmosomes and proposed roles of specific desmosomes. 
The desmosomal complex includes: desmosomal cadherins (i.e. desmocollin-2 [DSC2] and desmoglein-2 
[DSG2]), the armadillo proteins (i.e. junctional plakoglobin [JUP] and plakophilin-2 [PKP2]), and the plakins 
(desmoplakin [DSP]). PKP2 is the desmosomal region of interest which is circled in red. (Adapted and modified 
from :(Marcus et al., 2010)).  
 
In 2004, a South African research programme was launched to study the clinical characteristics 
and molecular genetics of ARVC in African populations. This was conducted under the 
auspices of the Cardiac Arrhythmia Society of Southern Africa (CASSA), and the ARVC 
registry of South Africa, based at Groote Schuur Hospital and the Department of Medicine of 
the University of Cape Town (UCT). This registry continually records data related to the 
natural history, prognosis, and efficacy of treatment and the genetics of ARVC in South Africa 
(Watkins et al., 2009).   
In 2009, owing to the referral of over 100 cardiomyopathy patients to the ARVC registry of 
South Africa, as well as the limited knowledge of cardiomyopathies in Africa, a study was 
performed to determine the clinical features, survival experience, and profile of the genetics of 
PKP2 gene mutations in ARVC (Watkins et al., 2009). They found the PKP2 gene to harbor 
the most common disease-causing mutations (13.9%) - the highest in the seven genes screened 
(5 desmosomal and 2 non-desmosomal genes). They also discovered the PKP2 c.1162C>T 
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(p.R388W) mutation in four Afrikaner probands. This, together with the absence of the variant 
in 241 healthy controls, suggested a founder effect in this population (Watkins et al., 2009).   
On further investigation, we found that these probands shared a common haplotype, indicating 
that the PKP2 c.1162C>T variant (Figure 3) was indeed a founder mutation. The Afrikaner 
population is possibly descended from a small pool of predominantly European founders, 
whose origins will be further explored in this study. Since 2009, the PKP2 c.1162C>T mutation 
has also been observed in other individuals of European descent but it is not known whether 
these individuals are related by descent or state to our South African cohort (Table 1). 
Figure 3: Schematic representation of the PKP2 gene. 
The location of the PKP2 founder mutation, c.1162C>T (p.R388W) is indicated (circled) with respect to other 
mutations. Black boxes indicate the exons, with disease causing mutations shown above them, and polymorphisms 





Table 1: Global distribution of the PKP2 c.1162C>T mutation in individuals of European ancestry. 
 
  
Title of paper / thesis/ Unpublished data Source Date/Year published Comment  
Unpublished data: Homozygous PKP2 c.1162C>T Provided by collaborator Dr Nathalie 
Roux-Buisson (Laboratoire de 
Biochimie et Génétique Moléculaire, 
IBP – DBTP 2ème Etage, CHU de 
Grenoble, CS10217 – 38043 Grenoble 
Cedex 9, France) 
2016 Collaborators identified an adult female with the first c.1162C>T 
homozygous PKP2 mutation, who presented with ventricular arrhythmias. 
Her mother is a heterozygous mutation carrier.  
Unpublished data: Insights into molecular and functional 






 2015 Present in Patient RY8012, PKP2 4 NM_001005242:c.C1162T: p.R388W 
Reads (<2% poor, >2% good). These results were observed after Next 
Generation Sequencing following a targeted-capture array on ARVC 
patients, i.e., in one patient originating from New Zealand. 
Stop-Gain Mutations in PKP2 Are Associated with a Later Age of 
Onset of Arrhythmogenic Right Ventricular Cardiomyopathy 
(Alcalde et al., 2014) 2014 Present in one Spanish patient. 
Unpublished data: Molecular basis for the diagnosis and etiology 
of genetically related cardiovascular disease as the cause of sudden 
cardiac death (Molekulare Grundlagen zur Diagnostik und 
Ätiologie genetisch bedingter kardiovaskulärer Erkrankungen als 
Auslöser des plötzlichen Herztodes) by Nadine Kiehne (translated 
from German thesis). 




2011 Present in a patient, Sample BN043; PKP2 Exon 4, R388W; German patient 
from the Kerckhoff Clinic group in Germany.  
Compound and Digenic Heterozygosity Contributes to 
Arrhythmogenic Right Ventricular Cardiomyopathy 
(Xu et al., 2010) 2010 Present in one North American ARVC patient (Patient 5) aged 16 and male.  
Clinical features, survival experience, and profile of plakophylin-
2 gene mutations in participants of the Arrhythmogenic Right 
Ventricular Cardiomyopathy Registry of South Africa 
(Watkins et al., 2009) 2009 Present in 4 white South African probands - self identified as Afrikaners. 
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According to the ARVC registry of South Africa, ARVC cases were observed more commonly 
in white and coloured than black South Africans possibly due to ascertainment bias caused by 
differences in access to healthcare. 
7.5 The founder effect in Afrikaners 
In this study, a progenitor (also section 5) refers to the original immigrant of a family to arrive 
in present day South Africa (Cardinal 2004); also known as a ‘founder'.  A founder effect occurs 
when a small subset of a large population establishes a new population. The new population 
may differ significantly from the original population, both in terms of its genotypes and 
phenotypes (Geldenhuys et al., 2014). In the case of South Africa, the first white settlers, led 
by Jan van Riebeeck (1652), arrived in Table Bay (Figure 4A) onboard three Dutch ships. As 
a result, the Cape Colony (Figure 4 A & B) was established and governed by the Dutch East 
India Company (VOC) until 1795. It was established as a re-supply and layover port for vessels 
of the VOC trading with Asia and later, the rest of the world. During this period, the Dutch 
Reformed Church (DRC/NGK) was established and began to keep records of congregants 
(Southey, 2001, Burrows, 1958).  
During the VOC rule in 1654 slaves were imported into the Cape Colony; some were later 
freed and married Dutch settlers or the Hottentots/Khoi Khoi. After the Edict of Fontainebleau 
or the Revocation (1685), France was in religious turmoil, banning Protestants’ religious 
freedom; this led to 200 French Huguenot (Calvinist Protestants of France) settlers arriving 
between 1688 and 1689. The Huguenots entered as refugees, had religious similarities with the 
Dutch and admixture into the modern day Afrikaner population occurred frequently. From 
1795-1802, the British occupied the Cape but were constantly at war against the Dutch and 
from the 1803, the Batavia Republic period commenced in the Cape Colony (Figure 4D). The 
British and the Dutch rarely admixed due to religious and colonial differences, both wanting to 
rule the lucrative Cape. In the 1820s, 5000 British settlers entered modern day South Africa, 
arriving at Port Elizabeth (Figure 4 A & D). In 1848, 163 German (Bergthiel) settlers arrived 




A                B 
 
C                           D 
 
Figure 4: Maps of South Africa between 1652-1915. 
(A) A map of the Cape colony 1652-1731 (Adapted from:(Guelke, 1988)).(B) Evolution of the Dutch Cape Colony, 
1700-1795. Cape town is highlighted in Dutch/Afrikaans,Kaapstad”(Adapted from:(www.revolvy.com, 2016)). 
(C) A Map of migration patterns of Trekboers (Adapted from: (www.revolvy.com, 2016)). (D) A Map of South 
African Wars (1879–1915). Footnote: Ethnic, political and social tensions among European colonial powers, 
indigenous Africans, and English and Dutch settlers led to open conflict in a series of wars and revolts between 
1879 and 1915 that would have lasting repercussions on the entire region of southern Africa. Pursuit of 
commercial empire as well as individual aspirations, especially after the discovery of gold (1886) and diamonds 




In the case of Afrikaners, the disorders that occur at an unusually high frequency may indicate 
that the original Dutch, French and/or German settlers in the Cape may have carried disease-
causing genes, and that consanguineous marriages heightened disease incidence (Geldenhuys 
et al., 2014). Previous founder studies in the Afrikaner population have demonstrated that 
founder mutations exist for heart diseases such as hypertrophic cardiomyopathy and long QT 
syndrome (LQTS) (Brink and Schwartz, 2009).  
The founder effect is believed to be predominantly observed in Afrikaner lineages due to 
geographical isolation (Geldenhuys et al., 2014). From previous studies, Afrikaner ancestors 
are commonly founded from Dutch (up to one third), German (less than a third) and French 
(approximately a quarter) roots that migrated to the modern day South Africa (previously 
known as the Cape of Good Hope) from the 1650s and onwards, in all parts of South Africa 
(Figure 4C). Furthermore, they have higher frequencies of intermarriages amongst them, which 
contributed to their genetic homogeneity (Geldenhuys et al., 2014, Greeff, 2007, Southey, 
2001, Burrows, 1958). Each modern day Afrikaner’s proportions of European and non-
European ancestry varies, and so will the segregation of a founder mutation in an isolated, 
mostly homogeneous population (Geldenhuys et al., 2014, Brink and Schwartz, 2009, Greeff, 
2007).  
The aim of this research project was to extend the families that had previously been found to 
harbor the PKP2 c.1162C>T mutation and to trace the common ancestor who entered modern 
day South Africa. The tracing method used was tailored for genetic genealogy, which has been 
a useful tool for human models of risk assessment in genetic health services (Stefansdottir et 
al., 2013). According to Geldenhuys (2014), ideally, 10 probands are required to find a 
common ancestor. 
The founder research was conducted similarly to the 2009 work done by Brink and Schwartz 
for the founder families with the long QT syndrome type 1 in South Africa and Geldenhuys’ 
(2014) work on Parkinson’s, respectively. The output includes the founder being named, as in 
the Brink and Schwartz (2009) paper, and a summarized pedigree to show how it was 
segregated as a human model (Geldenhuys et al., 2014, Brink and Schwartz, 2009). 
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8. Rationale of the study  
We hypothesized that during the 1650s, when the early Dutch or French settlers arrived in the 
Cape of Good Hope, at least one individual harbored the pathogenic mutation in the PKP2 gene 
which was passed on to subsequent generations; this may explain why the PKP2 c.1162C>T 
mutation is only found in modern day Afrikaners, who are historically known to marry within 
the community. A higher prevalence of certain genetic disorders in Afrikaners has been linked 
to the reduction in genetic variability from geographic isolation and religious and cultural 
bonds, coupled to rapid population expansion over 10-12 generations (Geldenhuys et al., 2014).  
As a result of the Watkins (2009) study, there was a need to validate and expand on the 
proposed founder effect observed in the Afrikaners, through genealogical tracing of the PKP2 
c.1162C>T mutation positive individuals and their shared common haplotype to find the 
common founder.  
9. Statement of research aim and objectives 
 
9.1 Main aim  
The aim of this study is to discover, through genealogical and molecular analysis, the common 
founder that introduced the PKP2, c.1162C>T mutation in the Afrikaner population of South 
Africa in families diagnosed with ARVC. 
 
9.2 Objectives  
1. To use high resolution melt (HRM) analysis to screen for the PKP2 c.1162C>T mutation in 
order to identify additional probands and their relatives.  
2. To construct the haplotype surrounding the PKP2 gene using the probands that are positive 
for the PKP2 c.1162C>T mutation. 
3. To identify the original founder with the PKP2 c.1162C>T mutation through genealogical 





10.1 Study design 
This was a descriptive study of ARVC cases from the ARVC registry of South Africa. The 
probands and their first degree relatives, who tested positive for the PKP2 c.1162C>T 
mutation, were recruited for this molecular and genealogical study of the founder effect. All 
study family trees of apparently unrelated probands with the PKP2 c.1162C>T mutation were 
traced using genealogical methods.  
This project forms part of a larger study on the genetics of cardiomyopathy that has been 
approved by the UCT Human Research Ethics Committee, HREC REF: 518/2016 (which 
incorporates the ARVC Registry of South Africa).  
 
10.2 Project Workflow 
After obtaining DNA from each study participant, laboratory work included the two phases of 
genotyping, i.e., screening by HRM and microsatellite analysis, then developing a haplotype. 
This was followed by the tracing of the PKP2 c.1162C>T mutation positive participants via 
genealogy (Figure 5).  
Figure 5: The three phases of the study’s data collection and analyses and reporting (in order). 
Namely, the two genotyping techniques i.e. HRM and Microsatellite, typing and finally, the human model via 




In summary, study participants were screened for the proposed founder mutation, c.1162C>T 
(through the PKP2 exon 4 genetic marker), and if found positive, were also tested for four other 
genetic markers spanning the PKP2 gene. Namely, PKP2 exon 11 genetic marker (for the 
Ins/del mutation i.e. c.2197_2202delCACACCinsG, A733fsX740 frameshift mutation (i.e. a 
deletion of 6 bases and the insertion of one base), and the 3 PKP2 microsatellite markers M1, 
D12S1692 and M2 (Blanckenberg, 2011, Watkins et al., 2009). After the genetic screening and 
shared common haplotypes were discovered, genealogical tracing was performed and to 
establish the common founder. 
 
10.3 Participant selection and diagnosis 
Physicians refer confirmed or suspected cases of ARVC and their first-degree relatives to the 
Cardiac Clinic, Groote Schuur Hospital (GSH), Cape Town, for consideration for enrolment in 
the registry.  
 
A standardized case report form was completed for all participants by the physician (as per 
standard operating procedures of the ARVC Registry of South Africa (Watkins et al., 2009)).  
All available probands and consenting family members were recruited into the registry after 
obtaining voluntary, informed consent (Appendix 2). The case report form and the notes of the 
genetic counsellor contained information on age, gender, ethnicity, presenting symptoms, 
family history (to commence genealogical tracing), electrocardiographic (ECG) findings, 
cardiac imaging studies, histology, outcome and genetic counselling (Fish et al., 2016).  
 
All samples were coded to anonymize and safeguard the confidentiality of the patients in the 
laboratory testing phase.  
However, for the genealogical aspect of the study all participants meeting the criteria were 
contacted again to determine the date of birth, names and locations of ancestors for 
genealogical tracing purposes. 
 
10.4. Selection criteria 
All participants entered into the ARVC registry of South Africa were investigated by a 
diagnostic panel consisting of a group of cardiologists who determined, by consensus, whether 
or not patients meet the 2010 ARVC Task Force Criteria (TFC) (Appendix 1). The study 
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participants were classified as having definite ARVC (if 2010 ARVC Task Force Criteria was 
met), probable or possible ARVC (if some criteria was met and no alternative diagnosis is 
found), or not affected with ARVC (if there was no evidence of ARVC and/or an alternative 
diagnosis present).  
 
10.4.1 Inclusion criteria 
Individuals in this study were included under two categories: 
A) They were (i) an ARVC patient that has met the 2010 ARVC TFC with the PKP2 
c.1162C>T mutation or (ii) a first degree relative of an ARVC patient with a PKP2 c.1162C>T 
mutation, i.e., the ‘ARVC at risk’ group; OR 
B) They carried the c.1162C>T mutation in exon 4 of the PKP2 gene. 
Occasionally, other relations of (A) such as second degree relatives and spouses were included, 
in the absence of first degree relatives and/or to clarify the lineage the mutation came from. 
10.4.2 Exclusion criteria 
Arrhythmogenic right ventricular cardiomyopathy patients without the PKP2 c.1162C>T 
mutation and individuals not related to the c.1162C>T mutation probands were excluded in the 
study. 
All patients with secondary causes of cardiomyopathy or left ventricular dysfunction (such as 
valvular heart disease, diabetes, coronary artery disease, or sepsis) were excluded from the 
study. 
 
10.5. Control selection 
Controls were chosen from a South African population comprised of anonymous blood donors. 
Their bloods were selected by ethnicity, as the c.1162C>T mutation was predominantly seen 
in those of white South African descent. Also included as controls were populations who self-
reported as Cape Mixed Ancestry. Informed consent was obtained from all controls. 
 
10.6 DNA extraction 
Written informed consent was obtained from all individuals enrolled in the study. As per the 
instructions of the manufacturer, the genomic DNA was extracted from 5-10ml EDTA blood 
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using the PureGeneTM DNA Purification System (Gentra systems, Qiagen, Hilden, Germany) 
(Fish et al., 2016). Extracted DNA samples were stored in 1.5ml Eppendorf tubes at -80°C, and 
a working sample of 50ng/ul was used for all downstream applications (Fish et al., 2016). 
 
10.7 Gel electrophoresis 
Electrophoresis is a separation technique used for charged particles (compounds) based on their 
electrical charge. Their size affects the speed of migration. Agarose is commonly used for DNA 
analysis and separation of Polymerase Chain Reaction (PCR) amplicons. The DNA is 
visualized in the gel by UV light shining over a fluorescent dye in the UVITec Gel Doc system 
(Uvitec, Cambridge, UK). This binds strongly to DNA by intercalating between (Hofmann et 
al., 2014) the bases and is fluorescent (absorbs invisible UV light and transmits the energy as 
visible light) via transillumination. 
Different ladder sizes are used according to the maximum expected size of bands, type of gel, 
visualization techniques used and the ruler or marker to use to compare or deduce size of a 
band in base pairs, vary (Hofmann et al., 2014). 
In this case, 2% Agarose gels were made by mixing 2 g Agarose powder (Roche) in 100 ml 1X 
TBE Buffer. It was heated and left to solidify, before immersion in 1X TBE solution in a gel 
tank. Then a loading dye mix (of Gel Red and Gel Green (Biotium)) was mixed with the 
Promega 100bp DNA ladder (Appendix 5), 3uL:5uL, respectively and loading dye mix and 
PCR product 3uL:7uL, respectively, and loaded onto the gel. The gels were electrophoresed at 
140 V for an hour and visualized in an UVITec Gel Doc system (Uvitec, Cambridge, UK).  
 
10.8 Primers 
Primers are short DNA oligonucleotide sequences (ideally18-25base pairs long) used to initiate 
annealing (Figure 6) and amplification. They work in the presence of Taq polymerase (the 
enzyme), MgCl2 (the catalyst) and deoxynucleotides (dNTPs) (the building blocks, i.e. a mix 
of nucleotides A, C, G and T) in a PCR reaction. Primer pairs are designed so that they bind to 
DNA encompassing the planned region of amplification. This allows the dNTPs and Taq 










Figure 6: The exemplary binding of a forward primer; not to scale. 
Adapted from : (NFSTC.org, 2012).  
 
10.8.1 Primer design bioinformatics tools 
The primers were designed to span the exon 4 and 11 regions of the PKP2 gene (Table 2) and 
the same technique used for the microsatellite markers (in section 10.11 Microsatellites) that 
span the PKP2 gene.  
The primers were used for combined real-time PCR and HRM analysis as well as for DNA 
sequencing, while the microsatellite markers were used for PCR and the products used for 
capillary electrophoresis to investigate microsatellites. 
Tools used to design the primers and genetic markers for microsatellites by Mbele and 
Blackenberg were extracted from their PhD theses methods (Mbele, 2014, Blanckenberg, 
2011); which included gene annotation via Ensembl (http://www.ensembl.org/index.html) and 
perlv5, manually searching for a primer, IDT OligoAnalyser 
(http://eu.idtdna.com/calc/analyzer) calculations to check ideal primer properties, NCBI primer 
blasting (http://blast.ncbi.nlm.nih.gov/Blast.cgi) the best sequences (by observing the ideal E 
values; in the nucleotide blast function) and ordering Custom DNA Oligos from Integrated 
DNA Technologies (IDT) (IDT, Coralville, Iowa, US). 
The following criteria were used to design primers and genetic markers for microsatellites: 
(1)18-25 base pairs (bps) long, (2) had good sequence diversity with minimal sequence repeats 
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and secondary structure, (3) melting at a temperature (Tm) of 45°C to 65°C, (4) at a GC content 
of 45% to 65%, and (5) carrying a G or C clamp at the 3’ end.  
  
10.8.2 PKP2 primers 
The PKP2 primers used in this study were designed by members of the Cardiovascular 
Genetics Laboratory at the Hatter Institute for Cardiovascular Research in Africa (HICRA), 
Cardiovascular group (Watkins et al., 2009) and are presented in Table 2. 
 
Table 2: Primer sequences used for the amplification of PKP2 exons 4 and 11. 
*Number (e.g. 4) denotes the exon; F= forward primer, R= reverse primer. (Adapted from: (Mbele, 2014)). NB: 
Exon 11 was also screened in order to validate the Watkins (2009) paper findings. 
 
10.9 Polymerase Chain Reaction 
10.9.1 Principle of PCR 
Polymerase Chain Reaction is a molecular method developed by Kary Mullis in the 1980s. It 
is based on the ability of DNA polymerase to synthesize new strands of DNA complementary 
to the offered template strand. Due to DNA polymerase’s ability to add a nucleotide only onto 
a preexisting 3'-OH group, it uses a primer to which it can add the first nucleotide. PCR enables 
a researcher to delineate a specific region of template sequence to amplify. At the end of the 
PCR reaction, the specific sequence will be accumulated in billions of copies (amplicons) 
(NCBI, 2016). 
Deoxyribonucleic acid segments of interest are amplified by means of PCR, to a high copy 
number, prior to use in downstream molecular applications, such as HRM and Microsatellite 
analysis in this study. PCR is a laboratory technique used to amplify specific input dsDNA 









Primer Name and Strand Sequence (5’-3’) 
4 291 
 
55 PKP2 Exon 4F AGT ATT CGC TGA GTC GTC TCT 








ACA TCA GTG GCT CAG ACA G  




which one half of the DNA duplex will dissociate to become single stranded DNA (ssDNA) 
and shows duplex stability (NCBI, 2016).  
 
10.9.2 Polymerase Chain Reaction Protocol 
The three phases of PCR are: 1) Denaturation i.e. separation by heat, from a dsDNA strand to 
a ssDNA strand; 2) Annealing i.e. forward and reverse primers bind to the regions they were 
designed for; complimentary to the ssDNA; and 3) Extension i.e. elongation of the strand at 
the complimentary side using Taq Polymerase (a heat- stable polymerase) and dNTPs (NCBI, 
2016). The PCR conditions are described in Table 3. 
Table 3: PCR conditions. 
* indicates temperature changes as per primer set 
 
10.10 High Resolution Melting Analyses  
10.10.1 Principle of HRM 
High resolution melt characterises nucleic acid samples according to their strand dissociation 
(melt) behavior, comparing the melt shape and the melt temperature profiles of DNA samples. 
The HRM process is the warming of the amplicon of DNA from approximately 50°C to 
approximately 95°C during which detectors monitor the thermally-induced DNA dissociation 
(Farrar et al., 2009). A high level of fluorescence is normal at the beginning of the HRM 
process, as there are billions of copies of the amplicon. In the HRM machine, when the melting 
temperature of the two strands is reached, the individual DNA strands melt apart. Hence, the 
amount of dsDNA in the solution decreases and as a result, the fluorescence of the solution 
decreases (Farrar et al., 2009). 
The HRM machine measures and records the fluorescence and plots it as a melting curve 
reflecting the changes in the fluorescence of the solution due to the rising temperature. Similar 
CONDITION TEMPERATURE & TIME 




94°C - 30 seconds 
* - 45 seconds                             33 cycles 
72°C - 50 seconds 
Final Elongation 72°C - 7 minutes 
Cooling (Optional) 4°C - 30 minutes 
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to the Tm principle in the PCR procedure, the midpoint of the melting curve, where the rate of 
change in fluorescence is the greatest, is the melting temperature (Tm) of the particular DNA 
fragment under analysis. The differences in DNA sequences, GC content and melting 
properties, also cause a difference in the melting temperature and the melting behavior of a 
DNA fragment. Sequence differences due to mutations including single nucleotide 
polymorphisms (SNPs), would thus change the melting temperature and be reflected in the 
melting curve (Farrar et al., 2009). 
For HRM analyses, the amplicon sequences were also restricted to a 250-350bp length, as 
increased amplicon size is known to lead to decreased resolution in amplicon screening and 
genetic variant detection with HRM (Farrar et al., 2009).  
 
10.10.2 High Resolution Melting protocol  
Genomic DNA was placed into the PCR reagent mix (Table 4), amplified to a  PCR product 
by the HRM conditions in Table 5 by binding with an intercalated dye (EvaGreen (AnaTech)) 
and then, melted in the RotorGene 6000 (Corbett Life Sciences) at the Cardiovascular Genetics 
(CVG) Laboratory of the Hatter Institute for Cardiovascular Research in Africa (HICRA) at 
UCT, as per their standard operating procedures and conditions (Fish et al., 2016). In this case, 
a RotorGene 6000 condenses the two steps into a single procedure (Table 5). 
The HRM method is sensitive enough to detect single base changes (Fish et al., 2016, Fish, 
2010). Once a change was identified, the samples were sequenced. 
Table 4: HRM Reagent Mix. 
 
Reagent (stock concentration) Volume per reaction 
Forward Primer (20 µM) 0.5 µl 
Reverse Primer (20 µM) 0.5 µl 
dNTPs (20 µM) (Bioline ) 1 µl 
GoTaq Polymerase (5 U/ ul ) (Promega) 0.1 µl 
GoTaq FlexiBuffer (5X) (Promega) 5 µl 
MgCl2 (25 mM) (Promega) 3 µl 
EvaGreen dye  (1X) (Anatech) 1 µl 
DNA (50ng/ µl) 1 µl 







Table 5: HRM Conditions  
 
10.11 Sanger Sequencing 
10.11.1 Principle of Sanger sequencing 
Deoxyribonucleic acid sequencing is the reading of the DNA strand, nucleotide by nucleotide. 
This is the Gold standard of mutation analysis. DNA sequencing was performed on all samples 
that showed a change in the HRM melting profile, in comparison to the controls. 
Sequencing is performed using PCR products as template DNA. During the sequencing 
reaction, this template is first denatured to form ssDNA. Next, a short oligonucleotide is 
annealed to the same position on each template strand. The oligonucleotide acts as a primer for 
the synthesis of a new DNA strand that will be complimentary to the template DNA. The 
sequencing reactions require the addition of all the components necessary to synthesize and 
label a target DNA template, a primer, DNA polymerase, 4 dNTPs and 4 ddNTPs (ddG, ddA, 
ddC, and ddT). The ddNTPs differ from dNTPs in that they lack a 3` hydroxyl group, and thus 
their incorporation into the chain of nucleotides prevents any further elongation. Because of 
this, the sequencing reaction produces ssDNA molecules that differ in length by just a single 
nucleotide; they can be separated from one another using capillary electrophoresis. In 
automated Sanger sequencing, fluorescently labeled ddNTPs are detected via laser firing. They 
fluoresce different colors, producing a chromatogram. The results are interpreted by 
bioinformatic analysis to display the absence or presence of SNP(s) or mutations (Smith-
Zagone et al., 2007). 
CONDITION TEMPERATURE & TIME 




95°C - 5 seconds 
55°C -10 seconds      50 cycles 
72°C - 10 seconds 
High Resolution Melt 72 - 95°C (0.1°C increments) 
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Sequencing was used to investigate PCR amplicons at the nucleotide level, in the samples in 
which a change in the HRM melting profile was observed in comparison to the controls. This 
provided additional and more specific genetic information for screening, future haplotyping 
and association studies. This is in order to primarily see if the relevant proband and its 
immediate family carried the same genetic SNPs/ mutations in the same exons, as their other 
family members; common for familial disease types.  
 
10.11.2 Sequencing protocol 
The HRM products were first purified (using the. Exonuclease I, Shrimp/ Thermosensitive 
Alkaline Phosphatase PCR Purification Kit) and prepared for sequencing (via the Big Dye 
Terminator Sequencing reaction). After the sequencing preparation reactions, the sequencing 
preparation products were analyzed using capillary electrophoresis at the DNA Sequencing 
Unit (Department of Genetics, Stellenbosch University), by means of the ABI PRISM® 
3130xl Genetic Analyser (Applied Biosystems) or the ABI PRISM® 3730xl Genetic 
Analyser (Applied Biosystems). The Sequencing Reaction and Analysis protocol were 
followed (Appendix 6). 
The DNA sequences generated in these experiments (.abi files) were aligned to the wildtype 
sequence that was gene annotated from the Ensembl database (http://www.ensembl.org/) using 
the BioEdit Sequence Alignment Editor (© Tom Hall). The ClustalW function was used to 
observe SNPs in Exon 4 and the Ins/Del in Exon 11. The chromatogram was checked for 
changes at position c.1162, with a C to T change expected in mutation carriers.  The changes 
were analyzed against the Sequencing Reaction and Analysis Protocol (Appendix 6). 
 
10.12 Microsatellites 
10.12.1 Principle of microsatellites 
Microsatellites are simple sequence tandem repeats. Naturally occurring in both coding and 
non-coding regions of the DNA; a few human genetic disorders are caused by (trinucleotide) 
microsatellite regions in coding regions. On each side of the repeat unit are flanking regions 
that consist of "unordered" DNA. The flanking regions are critical as they allow the 
development of locus-specific primers to amplify the microsatellites with PCR. The probability 
of finding an “unordered” particular stretch of DNA (i.e. a combination of simple sequence 
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tandem repeats and locus-specific flanking regions of DNA, sizing up to 100-500bps) more 
than once in the genome becomes vanishingly small (Wrent et al., 2016, Gabriel et al., 2002).  
The principle of microsatellite typing used short tandem repeat (STR) motifs, consisting of one 
to six nucleotide repeats (generally di-, tri- tetra- or penta- nucleotides, repeated from 8 to 50 
times) present in the genomes of all eukaryotes to map kinship (Wrent et al., 2016). According 
to Mendelian inheritance patterns, each allele of each microsatellite marker was expected to be 
inherited once from each respective parent, and only two alleles per marker were expected from 
each autosomal pair  (Gabriel et al., 2002).  
 
10.12.2 Microsatellite protocol 
 The microsatellites of interest were amplified via PCR (as previously described in Section 
10.9) using fluorescently tagged primers.  
Polymerase Chain Reaction products were electrophoresed on a 2% agarose gel (Section 10.7) 
to confirm if the reaction worked and optimized to the right product size and specificity. 
Subsequently, the PCR product, then underwent capillary electrophoresis and finally, was 
compared against the GeneScan ROX-labeled GS500 internal size standard (Applied 
Biosystems), to visualize the microsatellite profile of the three markers Tables 6-9).  
The microsatellite markers of interest were: PKP2_M1 (tagged with FAM, for dinucleotide CA 
repeats), PKP2_D12S1692 (tagged with HEX, for dinucleotide CA repeats) and PKP2_M2 
(tagged with HEX, for dinucleotide TG repeats), spanning over the PKP2 gene region. These 
identified the number of short tandem repeats in targeted microsatellite regions in the ABI 
Prism® 3130 XL Genetic Analyzer machine (Applied Biosystems, Foster City, CA, USA) at 
the Division of Human Genetics, UCT and the output data was analyzed using the GeneMapper 
version 4.0 software (Applied Biosystems) (Appendix 9). 
 
Table 6: PCR Reagents, M1 (for FAM labeled markers). 
Reagent Volume (ul); n=1 
Forward primer (20uM) 0.5 
Reverse primer (20uM) 0.5 
dNTPs (20mM) 1 
GoTaq Flexi Buffer (5X) 5 
GoTaq Polymerase (5U/ul) 0.1 
MgCl2 (25mM) 1.5 
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DNA (50ng/ul) 1 
dH20 15.4 
Total 25 
Table 7: PCR Reagents, D12S1692 & M2 (for HEX labelled markers). 
Reagent Volume (ul); n=1 
Forward primer (20uM) 0.5 
Reverse primer (20uM) 0.5 
dNTPs (20mM) 1 
GoTaq Flexi Buffer (5X) 5 
GoTaq Polymerase (5U/ul) 0.1 
MgCl2 (25mM) 3 




Table 8: PCR conditions. 
* indicates temperature changes as per primer set 
 
Table 9: Microsatellite marker sequences used and PCR product sizes for ARVC-9 Locus 
spanning the pathogenic PKP2 gene. 
 
*Number (e.g. 4) denotes the exon; F= forward primer, R= reverse primer. (Adapted from:(Blanckenberg, 2011)). 
CONDITION TEMPERATURE & TIME 




94°C - 30 seconds 
* - 45 seconds                             33 cycles 
72°C - 50 seconds 
Final Elongation 72°C - 7 minutes 

























































Generally, haplotyping is the observation of alleles on a single molecule. Usually, this is 
performed in conjunction with genotyping information and microsatellite analysis. This 
information is merged with relevant pedigrees to indicate patterns of inheritance of genotypes 
and ‘assumed haplotypes’ of unscreened parents.  
Construction of the most likely haplotype is designed with reference to the gene and STR (short 
tandem repeat) marker order on the respective chromosome, in the context of each family. The 
most probable haplotypes are constructed manually based on pedigree data and marker 
positions. In this study, in the few cases for which only the proband and a parent were available 
for genotyping, an “assumed haplotype”, based on the haplotype identified by family mapping, 
was generated (Moolman-Smook et al., 1999). 
 
10.14 Genealogy 
Genealogy is the study of families and the tracing of their ancestral lineages and history. The 
methods of genealogy usually include family tree construction, development of an ancestral 
chart, examination of the family register and use of the family chronicle or history and 
region/district genealogy  (Merwe, 2016). Genealogical data provide unique information for 
researchers in evolutionary and population genetics, demography and genetic epidemiology 
(Stefansdottir et al., 2013).  
 
10.15 Pedigree/family tree updates and consolidation 
Pedigrees and family trees were initially consolidated with the help of a genetic counsellor (Ms 
Nakita Verkijk, Division of Human Genetics, University of Cape Town), a physician (Dr Sarah 
Kraus, Department of Medicine, University of Cape Town) as well as an experienced 
genealogist (Professor Gerhard Geldenhuys, Genealogical Institute of South Africa, 
Stellenbosch University). The family histories collected by the Cardiovascular Genetics 
Laboratory were extended from follow-up interviews with study participants and all known 




10.16 Genealogical resources  
10.16.1 Western Cape facilities  
This study used standard methods for genetic genealogical research in South Africa on 
hereditary diseases including interviews, genetic analyses, the internet (including online 
database searches such as familysearch.org) and searches in historical records through sources 
(diagram of the key genealogical sources used to collect data, Figure 7) such as the 
Genealogical Institute of South Africa (GISA) in Stellenbosch (hosting microfiche or film of 
most early Afrikaner records). Furthermore, provincial state archives, Master’s offices (in 
Court), museum records, church records, death, marriage and baptismal registers, immigration 
records, estate papers, slave records, published genealogies (mostly in de Villiers/Pama (DVP) 
System), voters' rolls, telephone directories, property records and library records and tombstone 
inscriptions were used as resources to gather genealogical evidence as reported previously 
(Merwe, 2016, Geldenhuys et al., 2014).  
Finally, contacting or visiting the three mainstream Afrikaans churches, the Nederduitse 
Gereformeerde Kerk, the Gereformeerde Kerk and the Nederduitsch Hervormde Kerk van 
Afrika for detailed records of marriages and baptisms, was performed for any record 
discrepancies, or the provincial national archive were searched as they held the original, edited 













Figure 7: Western Cape Government facilities: Department of Cultural Affairs and Sport (DCAS) Facilities 
Web Map with all facilities for Genealogical Resources across the Western Cape Province. 




10.16.2 South African Public Records and Archival Considerations  
The researcher received training from experienced genealogist, Prof. Gerhard Geldenhuys. 
Secondly, supplementary training was provided by family search workshops at the Cape Town 
National Archives conducted by Principal Archivist Jaco van der Merwe. Subsequently, 
training for alternative methods for mixed ancestry research was provided by Aubrey 
Springveldt. As a result, the researcher was able to trace most of the family ancestral lines over 
the course of a year.  
Under the Promotion of Access to Information Act (PAIA), which informs much of the 
advocacy of the Archival Platform, the general public cannot access information, except in the 
public interest. Furthermore, there is a 100-year Department of Home Affairs document access 
ban spanning records from 1916-2016. However, for this research, the medical purposes for 
research were found to comply with the latest amendment of the National Archives of South 
Africa Act No 43 of 1996. I was trained adequately and hence, granted verbal approval to 
access some records inclusive of the last 100 years, exclusively for research purposes, as long 
as they were pre-authorized and signed by the Head of Civil Client services in that archive 
(Appendix 3).  
Finally, the National Archives require a copy of any genealogy or medical research that has 
used their facilities to be kept in their archive as an archival record. All information regarding 
individuals in the 100-year ban has been excluded from the archival record, and it will be kept 
in their respective private collections. 
10.16.3 Genealogical software 
During tracing, Legacy v8.0 Deluxe Edition Software was used to store, manage, merge, 
collaborate and analyze the large amount of data generated. For example, each proband had 
two parents, four grandparents, eight great-grandparents, and this number doubles in each 
subsequent generation, except when close relatives marry. Several generations in the family 
trees of the study participants, i.e., over 350 years or up to the earliest recorded migrant into 
South Africa, were explored and the information gathered to find a common founder 




11. Results  
11.1 Phenotype  
The probands and their families were referred to the Cardiac Clinic at Groote Schuur Hospital 
where the ARVC Registry was established in 2004. The families were coded in chronological 
order, according to which proband was recruited first. Due to family members migrating and 
limited resources, some of the study participants have not been phenotyped by the Diagnostic 
Panel of cardiologists at the Cardiac Clinic. Some study participants reside in other countries 
and others are in other provinces, such as Gauteng and the Free State province or have died.  
However, some were screened by their referring physicians and the screening data was 
extrapolated from the registry data in order to classify them into definite ARVC, probable 
ARVC, not affected or other diagnosis. Tables 10 to 16 show the phenotypic profile of 7 
families with ARVC due to the founder mutation in PKP2. 
*It would have been preferred to place the tables and pedigrees after each family subheading but due to the 
landscape orientation of the tables and to avoid unnecessary repetition of the pedigrees, they were placed at the 
end of section 11.1 (tables) and section 11.2 (mutation-related pedigrees). 
 
11.1.1. ACM 5 family  
Six of the family members were screened, including the proband; the rest had an unknown 
phenotype (Table 10). The phenotypic profile of the three affected family members in ACM 5 
presented showed moderate disease. The ACM 5 family proband, ACM 5.1, was a competitive 
marathon runner who presented with symptoms of ARVC at 44 years associated with 
ventricular tachycardia (VT). Her brother (ACM 5.5) also had adult-onset ARVC. However, 
the daughter of ACM 5.5 (ACM 5.11) presented with ARVC during her adolescence.  
 
11.1.2. ACM 8 family  
Three of the family members, including the proband, were screened, whereas the rest had either 
an incomplete or unknown phenotype status (Table 11). The phenotypic profile of the two 
affected family members in the ACM 8 family was consistent with severe early-onset disease 
in adolescence with VT. The ACM 8 family proband, ACM 8.3, presented at 13 years and 
received a heart transplant at 23 years. Her younger brother presented at 12 years and died from 
SCD in 2004 (at 14 years). The mother, ACM 8.2 is symptomatic with definite features of 
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ARVC (albeit mild) but we have not phenotyped the father who has yet to responded to 
invitations to visit Groote Schuur Hospital. 
 
11.1.3. ACM 12 family 
Only the proband in this family was screened. The proband did not want the rest of the family 
to be recruited nor their status to be disclosed. This proband presented with moderate, late 
disease onset (Table 12).  ACM 12.1 presented at the age of 45 with VT and was a competitive 
marathon runner. 
 
11.1.4. ACM 19 family 
Seven family members were phenotyped including the proband; the rest had incomplete or 
unknown phenotypes (Table 13). The phenotypic profile of the three affected family members 
in the ACM 19 family was of severe disease (ACM 19.1 and ACM19.2, requiring heart 
transplants during adolescence) and ACM 19.13 with moderate disease, all with VT.  The ACM 
19.1 and ACM 19.2 siblings presented with an early onset of ARVC during adolescence, aged 
14 and 11, respectively. Both parents (ACM19.3 and ACM 19.6) were asymptomatic in their 
50s however; their mother (ACM19.6) met borderline ARVC 2010 criteria. The cousin, 
ACM19.13, from the mother’s side, recently presented later with symptoms of ARVC at the 
age 32.   
 
11.1.5. ACM 38 family 
Three family members were phenotyped, including the proband, whereas the rest had an 
incomplete or unknown phenotype (Table 14). The phenotypic profile of the three affected 
siblings (ACM 38.3, ACM38.5 and a deceased sister, who died at 8 years from SCD) was that 
of severe disease before adolescence (from as early as the age of 8 years). ACM 38.3 received 
a heart transplant at 16 years and ACM 38.5 at 8 years), all with VT. The parents were not 
phenotyped. It is noteworthy that the mother (ACM 38.2) had a history of recurrent 




11.1.6. ACM 57 family 
Only the proband in this family was phenotyped. The proband did not want the rest of the 
family to be recruited nor their status disclosed. This proband presented with adult-onset 
moderate disease (Table 15).  ACM 57.1 presented at the age of 42 years with VT and was a 
competitive marathon runner. 
 
11.1.7. ACM 71 family 
Only the proband in this family was phenotyped (ACM71.1). The rest had an incomplete or 
unknown phenotype (Table 16). This proband presented at the age of 38 years with moderate 
disease. ACM 71.1 was a farm worker with a history of hypertension and smoking (inclusive 




Table 10: Phenotypic profile of the ACM 5 family.  




Symptomatic  Diagnosis by 2010 
TFC 
Heart transplant  SCD ARVC confirmed 
Pathologically  
ACM 5.10 1992/10/07 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 5.11 2000/06/26 Positive Yes-2015 Yes Possible* No No N/A 
ACM 5.12 1953/07/15 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM 5.13 1951/03/23 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM 5.14 1982/02/01 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM 5.15 1974/12/01 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 5.1 
(Proband) 
1958/07/17 Positive Yes-2002 Yes Definite No No N/A 
ACM 5.2REN 1981/05/21 Negative Yes-2010 No (Known with 
WPW) 
No criteria No No N/A 
ACM 5.3 1982/06/12 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 5.4 1958/07/17 Positive Yes-2010 Unknown Definite* Unknown Unknown Unknown 
ACM 5.5 1963/02/22 Positive Yes- 2013 Yes Definite* No No N/A 
ACM 5.6 1979/06/07 Positive Yes-2013 No Possible* No No N/A 
ACM 5.7 1961/09/01 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 5.8 1955/09/21 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM 5.9 1966/01/26 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 
*- Major for family history  
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Table 11: Phenotypic profile of the ACM 8 family.  
DNA ID DOB RESULT (c.1162C>T) Clinically screened, 
Year 
Symptomatic  Diagnosis by 2010 
TFC 
Heart transplant  SCD ARVC confirmed 
Pathologically  
ACM8.10 1954/11/17 Positive No Unknown Possible* Unknown Unknown Unknown 
ACM8.2 1959/01/22 Positive Yes-2010 No Definite* No No N/A 
ACM 8.3 
(PROBAND) 1988/10/21 Positive Yes-2001 Yes Definite Yes No Yes 
ACM8.4 1990/10/15 Positive Yes- 2002 Yes Definite No Yes Yes 
ACM8.9 1986/10/21 Negative No Unknown Unknown Unknown Unknown Unknown 
 ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 
*- Major for family history 
 
Table 12: Phenotypic profile of the ACM 12 family.  




Symptomatic  Diagnosis by 2010 
TFC 




1953/09/25 Positive Yes-2003 Yes Definite No No No 
 ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 








Table 13: Phenotypic profile of the ACM 19 family. 




Symptomatic  Diagnosis by 2010 
TFC 
Heart transplant  SCD ARVC confirmed 
Pathologically  
ACM 19.10 1933/04/07 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM 19.11 1988/10/07 Positive No No Unknown Unknown Unknown Unknown 
ACM 19.12 1984/10/10 Positive No No Unknown Unknown Unknown Unknown 
ACM 19.13 1983/03/10 Positive Yes-2016 Yes No criteria No No N/A 
ACM 19.1 1991/07/09 Positive (Known to 
also have the PKP2 
Exon 11 ins/del 
mutation) 
Yes- 2005 Yes Definite Yes No Yes 
ACM 19.2 
(PROBAND) 
1985/02/13 Positive (Known to 
also have the PKP2 
Exon 11 ins/del 
mutation) 
Yes-2006 Yes Definite Yes No Unknown  
ACM 19.3 1957/07/18 Negative (Known to 
also have the PKP2 
Exon 11 ins/del 
mutation) 
Yes- 2006 No Possible * No No N/A 
ACM 19.4 1982/09/08 Positive Yes- 2008 No Possible * No No N/A 
ACM 19.5 1987/07/13 Negative Yes- 2009 No Possible * No No N/A 
ACM 19.6 1956/09/14 Positive Yes-2009 No Borderline* Unknown No N/A 
ACM 19.7 1929/09/26 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 19.9 1958/10/26 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 




Table 14: Phenotypic profile of the ACM 38 family. 




Symptomatic  Diagnosis by 2010 
TFC 
Heart transplant  SCD ARVC confirmed 
Pathologically  
ACM 38.1 1953/08/11 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 38.2 1955/09/21 Positive  No  Unknown Unknown Unknown Unknown Unknown 
ACM 38.3 
(PROBAND) 
1983/05/06 Positive  Yes-1993 Yes Definite Yes-1999 No Yes 
ACM 38.4 1985/12/17 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 38.5 1990/05/04 Positive  Yes- 1997 Yes Definite  Yes-1998 Alive in 2009 Yes 
ACM 38.6 1957/10/25 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 38.7 1954/05/04 Negative No Unknown Unknown Unknown Unknown Unknown 
Sister of  Proband  1986/09/18 No DNA Yes-1990 Yes Incomplete records No Yes- died at 8 years 
of age 
Unknown 
ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 
*- Major for family history 
 
Table 15: Phenotypic profile of the ACM 57 family.  




Symptomatic  Diagnosis by 2010 
TFC 
Heart transplant  SCD ARVC confirmed 
Pathologically  
ACM 57.1 
(PROBAND) 1962/01/04 Positive Yes-2004 Yes Definite No No N/A 
 ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 





Table 16: Phenotypic profile of the ACM 71 family. 
 




Symptomatic  Diagnosis by 2010 
TFC 




1971/05/02 Positive Yes-2010 Yes Definite No No N/A 
ACM 71.2 1967/08/26 Positive No Unknown Unknown Unknown Unknown Unknown 
ACM 71.3 1966/06/19 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 71.4 1970/05/10 Negative No Unknown Unknown Unknown Unknown Unknown 
ACM 71.5 1946/03/09 Positive No Unknown Unknown Unknown Unknown Unknown 
 ACM – CVG database Arrythmogenic Cardiomyopathy coding abbreviation; ARVC- Arrhythmogenic Right Ventricular Cardiomyopathy; DOB- Date of Birth 
(YYYY/MM/DD); DNA ID- CVG database DNA sample ID; SCD – Sudden Cardiac Death; TFC –Task Force Criteria; WPW- Wolff-Parkinson-White syndrome 
2010 ARVC Diagnostic Task Force Criteria Definitions: 
Definite – 2 major criteria, or 1 major plus 2 minor criteria, or 4 minor criteria (2010 TFC); Possible- has family history; Borderline – 1 major and 1 minor, or 3 minor 
criteria (2010 TFC); met some but not all of the 2010 ARVC TFC ; Possible – 1 major criteria, or 2 minor criteria (2010 TFC) 




11.2 Genotype  
11.2.1 PKP2 c.1162C>T (p.R388W) 
A study in 2009 screened the PKP2 gene and identified a recurrent PKP2 c.1162C>T mutation 
in exon 4 in four Afrikaner probands (Figure 8) (Watkins et al., 2009). We extended the study 
and included not only the four initial probands but their core families as well. We continued 
screening all new ARVC probands and when a PKP2 c.1162C>T carrier was found we 
included them and their nuclear families in our founder study. 
 
Figure 8: Mutation peaks from (A) Exon 4; Red is ACM71.1 (mutation positive study participant) and Blue is 
the control results. 
There were 46 probands and families who underwent molecular screening for the PKP2 
c.1162C>T mutation in 2016 (Table 17).  
Table 17: Study participants screened for PKP2 c.1162C>T change and common haplotype. 




ACM 5 15 10 10 
ACM 8 5 4 4 
ACM 12 1 1 1 
ACM 19 12 8 8 
ACM 38 7 3 3 
ACM 57 1 1 1 
ACM 71 5 3 3 
Total Participants 46 30 30 
Where possible, we extended and tested the families to include aunts, uncles and cousins that 
were at risk or those that showed signs and symptoms of heart disease (Figure 9-15). 
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Figure 9: ACM 5 Family PKP2 c.1162C>T mutation status. 
+ tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does not 
carry the variant; +/-heterozygous carrier; +/+ homozygous carrier; -/- non-carrier. NB: ACM5.1 has an 
assumed heterozygous state from the Watkins (2009) paper; supported by the ACM5.4 (ACM5.1 twin’s) sample. 
 











Figure 10: ACM 8 Family PKP2 c.1162C>T mutation status. 
+ tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does not 































Figure 11: ACM 12 Family PKP2 c.1162C>T mutation status. 
+ tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does not 




















Figure 12: ACM 19 Family PKP2 c.1162C>T mutation status. 
+ tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does not 





























Figure 13: ACM 38 Family PKP2 c.1162C>T mutation status. 
+ tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does not 
carry the variant; +/-heterozygous carrier; +/+ homozygous carrier; -/- non-carrier 
 










Figure 14: ACM 57 Family PKP2 c.1162C>T mutation status. 
+ tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does not 























Figure 15: ACM 71 Family PKP2 c.1162C>T Mutation Status. 
+- + tested positive for the mutation and carries the mutated variant;   tested negative for the mutation and does 
not carry the variant; +/-heterozygous carrier; +/+ homozygous carrier; -/- non-carrier 
 
11.2.2 Microsatellites 
The microsatellite markers used to construct the haplotype were: PKP2_M1 (tagged with FAM, 
for dinucleotide CA repeats), PKP2_D12S1692 (tagged with HEX, for dinucleotide CA 
repeats) and PKP2_M2 (tagged with HEX, for dinucleotide TG repeats), spanning the entire 
PKP2 gene as well as the 5’ and 3’ region. Microsatellites were visualized on the ABI 3130XL 
via stutter peaks; often with the largest peak observed as the “unordered” stretch of DNA’s 
size. They are detected using fluorescence; from the fluorescently labelled tags (HEX 
(green)/FAM (blue)).  




















Figure 16: Microsatellite Analysis of ACM71.1. 
(A) M1 (183), Peaks sized at 167bps (blue circle) and 183 bps (red circle). M1 common haplotype peak is 183bps, 
(B) D12S1692 (247), Peaks sized at 247bps (red circle) and 257 bps (blue circle). D12S1692 common haplotype 




Merging the genotype and microsatellite typing results enabled us to determine various 
haplotypes i.e. identifying a group of alleles inherited by progeny from each parent.  
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[Grab your reader’s attention with a 
great quote from the document or 
use this space to emphasize a key 
point. To place this text box 
anywhere on the page, just drag it.] 
Haplotype-based methods offer a powerful approach to disease gene mapping, based on the 
association between causal mutations and the ancestral haplotypes on which they arose 
(Gabriel et al., 2002). 
For this study a haplotype was constructed which encompassed three mutations, PKP2 
c.1097T>C, PKP2 c.1162C>T and PKP2 c.2197-2202 Ins/Del and three microsatellite markers 
(M1, D12S1692 and M2) across the PKP2 gene. The resultant haplotypes underwent intra- and 
inter-family comparisons, in order to find if a common haplotype emerged for the c.1162C>T 
positive carriers. A common haplotype (Figure 17 A-G) emerged that segregated amongst all 




Footnote: (1)ACM  5.1 had no DNA sample available during DNA halpotyping; however, (MM (Watkins et al., 2009) and DG 
i.e. experiments run by Dimakatso Gumede in 2014 (unpublished) found   a common haplotype in this proband. Due to the 
twin, also presenting the same c.1162C>T mutation and common haplotype, the proband was shaded to indicate they carry 
the PKP2 c.1162C>T mutation.(2) Probands of the PKP2 c.1162C>T mutation are identified by arrows. (3)Males are 
indicated by boxes and females by circles. (4) PKP2 c.1162C>T mutation carriers are shaded and non –carriers are not 






















Footnote: (1) Probands of PKP2 the c.1162C>T mutation are identified by arrows. (2)Males are 
indicated by boxes and females by circles. (3) PKP2 c.1162C>T mutation carriers are shaded and 
non –carriers are not shaded.(4) Lines on the boxes or circles mean the individual is deceased at 




Footnote: (1) Probands of PKP2 the c.1162C>T mutation are identified by arrows. (2)Males are 
indicated by boxes and females by circles. (3) PKP2 c.1162C>T mutation carriers are shaded and 
non –carriers are not shaded.(4) Lines on the boxes or circles mean the individual is deceased at 































Footnote: (1) ACM 19.3, the proband’s father, has a known PKP2 c.2197_2202delCACACCinsG 
mutation (Watkins et al., 2009). Shaded box with checked box. (2) Probands of the PKP2 c.1162C>T 
mutation are identified by arrows. (3)Males are indicated by boxes and females by circles. (4) PKP2 
c.1162C>T mutation carriers are shaded and non –carriers are not shaded.(5) Lines on the boxes 















Footnote: (1) Probands of the PKP2 c.1162C>T mutation are identified by arrows. (2)Males are 
indicated by boxes and females by circles. (3) PKP2 c.1162C>T mutation carriers are shaded and 
non –carriers are not shaded.(4) Lines on the boxes or circles mean the individual is deceased at 
time of schematic presentation of pedigree.(5) The band on ACM 38.5 indicates possible 






Footnote: (1) Probands of the PKP2 c.1162C>T mutation are identified by arrows. (2)Males are 
indicated by boxes and females by circles. (3) PKP2 c.1162C>T mutation carriers are shaded and 
non –carriers are not shaded.(4) Lines on the boxes or circles mean the individual is deceased at 





























Footnote: (1) Probands of the PKP2 c.1162C>T mutation are identified by arrows. (2)Males are indicated by 
boxes and females by circles. (3) PKP2 c.1162C>T mutation carriers are shaded and non –carriers are not 
shaded.(4) Lines on the boxes or circles mean the individual is deceased at time of schematic presentation of 
pedigree. 
 
Figure 17: Haplotype summary for all study participants; grouped per family (ACM 5 to 71) labelled A to G, 
respectively. 
 
11.3. Genealogical tracing  
Of interest to us was the oldest family member to pass on the PKP2 c.1162C>T mutation as 
this is where we started genealogical tracing-right up until the 17th century or where the first 
founding ancestors entered.  
This study used standard methods for genetic genealogical research in South Africa on 
hereditary diseases; all resources used are mentioned in section 10.16. The haplotype analyses 
reports were used to include or exclude specific ancestral lines from genealogical tracing, based 
on their patterns of inheritance. 
We started the genealogical tracing arm of this project by using the most complete family 
available as this would allow us to identify all possible common founder couples.  Location of 
the families in the past and the present was an important source of information as it dictated 








(churches/archives/Master’s office) in the area where the current descendants were living, 
baptized or died.   
Each mutation positive proband’s ancestral lines were traced as far back as the records would 
allow. Some family lines had complete South African family trees from as early as the 17th 
century when their ancestors had disembarked from ships on the coasts of South Africa. 
The order of the families in this section was determined by the amount of available information 
in that family and how much they contributed to the identification of the final list of common 
founder couples. 
 
11.3.1. ACM 38 family 
The most complete family traced was ACM 38. With limited information (provided by the 
genetic counsellor) mostly names, estimated dates of birth (DOB) and places of residence of 
the proband, their parent and grandparents, we started tracing the ancestral lines of this family. 
We determined that the ACM 38 family mostly resided in Cape Town and had lost contact with 
extended family members. We started looking at all the available information (per individual) 
in the local repositories on this family (section 10.16 on genealogical resources).  
Guided by the fact that the genotypes indicated that the PKP2 c.1162C>T mutation was 
inherited via the maternal line (ACM38.2), we extended both the maternal and paternal lines 
of ACM38.3 (Figure 17E). We searched for the maternal grandmother and her parents in the 
South African Genealogies, SAGs (17 Volumes) (Figure 18) and then the South African 
Families, SAFs (34 Volumes) manually, using the DVP System (DVP system, 1995). After 
reaching an impasse we began to search for the grandmother’s progenitors in alternative 
records such as the Microfilmed 1984 South African Voter’s Roll at GISA (Figure 19); this 
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Figure 18: South African Genealogies (SAGs) and the de Villiers/Pama  (DVP) System. 
(A) SAGs (South African Genealogies). The latest 17 volumes are accessible at GISA. (Adapted from: 
http://www.gisa.org.za/site/node/12). These volumes are read only using the DVP system; (B) The sample generic 
chart on the left above is adapted from Genealogical Numbering Systems. Inside each volume page, one must 
check manually to find the individual of interest, their parents and ancestors, which are usually in earlier lettering. 
Hence, these books are read from back (large page numbers) to front (smaller page numbers) and each page read 













Figure 19: Microfilm searches at GISA. 





Investigation of the paternal line of the proband (ACM38.2) found the South African surname 
progenitor arriving in the old Cape Province from Netherlands and then marrying a French 
Huguenot progenitor’s offspring in the 17th Century. Most of them were born and resided in 
the old Cape Province, excluding the few generations that moved to the old Transvaal region 
and married English spouses. Using the resources in this area lead to a collaboration with a 
family researcher who had published other sections of his work on this common Dutch family 
over the past 20 years. The researcher provided the missing family data from his private archive 
as well as the Pretoria National Archives. I also collected data from the death notices from the 
old Transvaal death indexes in the Western Cape Archives (only 1910-1943). Some baptismal 
and marriage records were also traced at GISA on microfilms, referenced per town or city in 
that region from the earliest town established in 1852 up to 1902; under the changing location 
names (as per the changed British and VOC leadership after the Anglo-Boer Wars; some 
regions had names changed). 
Records showed that the grandfather of ACM 38.2 returned to the Western Cape and that her 
maternal line had progenitors from the Netherlands, France and Germany (between the 17th 
and 18th century), mostly resident in the old Cape Province region. The ancestral lines also 
showed marriages to ‘free’ female slaves in the 17th century.  In over-all ancestry, a few 
duplicates were observed as consanguineous marriages occurred- mostly in the 17th and 18th 
Century. 
The results for this family showed South African progenitors dating back more than 10 
generations to as early as the 17th century.  This family search generated 1588 individuals.  
All data was entered into Legacy 8.0 deluxe edition, analyzed manually and the statistics 





Figure 20: All relatives genealogically traced of ACM38.2 in a tabular report. 
* As per Legacy v8.0 Deluxe Edition Software output. 
 
11.3.2. ACM 19 family 
With limited information (names, estimated DOB and places of residence of the proband, their 
parents and grandparents) provided by the genetic counsellor, we started tracing this family. 
We determined that the ACM 19 family mostly resided in the North West region of South 
Africa and started using all the available information (per individual) in the local repositories 
on this family (section 10.16 on genealogical resources).  
Guided by the fact that the genotypes indicated that the PKP2 c.1162C>T mutation was 
inherited via the maternal line (ACM19.6), we extended both the maternal and paternal lines 
of the mother’s family (Figure 17D). Through ACM19.6 we determined that her father resided 
in the North West Province but that the grandparents’ family resided in the Free State; 
numerous family members had also relocated to New Zealand. We searched for the paternal 
family of ACM 19.6 in the SAGs and then the SAFs; manually, using the DVP system.  
Parts of the paternal family were previously researched and found in the SAGs and SAFs. We 
also began to search for the missing paternal line of ACM19.6, namely, her paternal 
grandmother in alternative records such as the microfilmed baptismal records at GISA (Figure 
19) and death notices at the Western Cape archives.  This confirmed a lot of the information 
we had started with and provided the following generation’s details and next set of traceable 
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records- including some eGSSA data sources such as their cemetery project that took pictures 
of most of the cemeteries.   
The paternal line of ACM19.6 was traced back and had the South African surname progenitor 
arriving in the old Cape Province from Germany and married a Dutch progenitor’s daughter, 
whose mother was a slave in the 17th Century. Most of them resided and were born in the old 
Cape Province. A few lines of descent were observed in the Eastern Cape and Free State region 
after the 20th century, that eventually moved to the Free State region and most present day 
descendants are still in the North West region and sparsely spread around the country, and 
others have migrated outside of the country.  
Other ancestral lines have progenitors that include the Netherlands, France and Germany 
(between the 17th and 18th Century); mostly resident in the old Cape Province region. The 
progenitors married English spouses in the 18th and 19th century, and over all the family trees, 
a few duplicates were observed, due to consanguineous marriages. 
The results for this family showed South African progenitors dating back more than 10 
generations to as early as the 17th century.  From the ACM 19 family alone we managed to 
trace 2224 individuals. By comparing ACM 38 to the ACM 19 family, we generated 116 South 
African candidate founding couples.  
We entered all the data into Legacy 8.0 deluxe edition, the data was analyzed manually and the 
statistics reported (Figure 21). 
  
Figure 21: All relatives genealogically traced of ACM19.6’s father in a tabular report.  




11.3.3. ACM 5 family 
With information pertaining to names, estimated DOB and places of residence of the proband, 
their parents, grandparents and great-grandparents (provided by the genetic counsellor) we 
started tracing the ancestral lines of this family. We determined that the proband (ACM 5.1) 
resided in the Western Cape Province and her twin sister (ACM 5.4) resided in the Eastern 
Cape Province; they were the eldest traceable carriers of the PKP2 c.1162C>T mutation. 
According to the sources the rest of the ACM 5 family mostly resided in the Free State region 
of South Africa. With this information we started using all the available information (per 
individual) in the local repositories on this family (section 10.16 on genealogical resources). 
We traced both maternal and paternal lineages of their parents, starting from the Free State 
region. Numerous living family members have relocated across all South Africa’s five 
Provinces, and outside the country, namely, Amsterdam and Australia. The parents of ACM 
5.1 and ACM 5.4 were not found in the SAGs and the SAFs, using the DVP system. Published 
family books and bibles on the progenitor surnames were first searched for the parents, and 
parts of the extended family were previously researched, but not the progenitor lines we were 
searching for. This led to searching the Free State death Index records available at the Western 
Cape Archives and the Orange Free State (OVS) files at GISA, where we found the marriage 
register and the death notices of the parents. We also did a search on FamilySearch.org to find 
the 20th century records, as their original copies are in the Free State. After this discovery, we 
found the rest of the lineages through collaboration with the Free State Archives (source of all 
Home Affairs documents), Free State Master of the High Court (MHG) Office (for death 
notices) and the Free State NGK (Dutch Reformed Church), for baptismal records. The NGK’s 
newly computerized registers made finding the baptismal and marriage registers relatively 
easy. Some periods still had to be manually checked at GISA and at the Western Cape Archives 
as their records are not complete and not all ancestors (1) got married in the NGK (2) baptised 
their progeny in Free State or (3) married spouses from that region. The SAGs and SAFs also 
complemented a lot of the information as we collected and provided the previous generation’s 
details and next set of traceable records.   
The paternal line of ACM5.1 was traced back and had the South African surname progenitor 
arriving in the old Cape Province from Germany and married a Dutch progenitor’s daughter, 
whose mother was Belgian in the 17th century. Most of them have resided and were born in the 
old Cape Province and in the old OVS. A few lines of descent were observed in other regions 
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such as the Eastern Cape region after the 20th century, that eventually moved back to the Free 
State region and others have migrated outside of the country. Other ancestral lines have 
progenitors that include the French Huguenots, the English and the Swiss (between the 17th 
and 18th century), mostly resident in the old Cape Province. Over all the family trees, a few 
duplicates were observed, mainly due to consanguineous marriages. 
The results for this family showed South African progenitors dating over 10 generations back 
to as early as the 17th century.  From the ACM 5 family alone we managed to trace 1078 
individuals.  By combining the genealogy data for ACM 38, ACM 19 and ACM 5 we generated 
10 common South African founding couples. 
We entered all the data into Legacy 8.0 deluxe edition, the data was analyzed manually and the 
statistics reported (Figure 22).   
 
Figure 22: All relatives genealogically traced of ACM5.1 in a tabular report. 
* As per Legacy v8.0 Deluxe Edition Software output. 
 
11.3.4. ACM 12 family 
With very limited information on names, estimated dates of birth and places of residence of the 
proband and his parents (provided by the genetic counsellor), we started tracing the ancestral 
lines of this family. We determined that the proband (ACM 12.1) resided in the Western Cape 
region. With this information we started using all the available information (per individual) in 
the local repositories on this family (section 10.16 on genealogical resources).  
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As we did not have the DNA of the proband’s parents available for testing we were not able to 
indicate from which parental line the PKP2 c.1162C>T mutation was inherited and proceeded 
to extend both maternal and paternal lineages of the proband. We started from the South 
African Voter’s Roll of 1984 under the Western Cape region which then led to searching the 
Western Cape Death Index records available at the Western Cape Archives and the Western 
Cape files at GISA. Here we found the marriage register and the death notices of the parents 
and other extended family members for the last three centuries. 
Our data revealed that the paternal lineage of ACM 12.1 has historically resided in the Western 
Cape Province, and the progenitor couples were both French Huguenots. The paternal line only 
mixed with the English from the 20th century and Dutch ancestral lines in the 18th century. The 
maternal lineage’s progenitor came in from France but was of German/Swiss/Jewish 
(Ashkenazi) origins and was married to a Flemish/Dutch progenitor’s daughter. They were the 
only family members who were screened for the PKP2 c.1162C>T mutation.  
 The family of ACM 12.1 is a well-known Huguenot family who had been partially researched 
from the 18th century and earlier. They had data extracted from the SAGs and the SAFs using 
the DVP system. Published family books and bibles on the progenitor surnames were also 
searched and helped start and expand the family tree. Over all the trees, a few duplicates were 
observed, as cousins inter-married. 
The results for this family showed South African progenitors dating back well over 10 
generations to as early as the 17th century. This family search generated 1430 individuals. By 
combining the genealogy data for ACM38, ACM19, ACM5 and ACM 12, we generated 5 
candidate South African founding couples. 
We entered all the data into Legacy 8.0 deluxe edition, the data were analyzed manually and 




Figure 23: All relatives genealogically traced of ACM12.1 in a tabular report. 
* As per Legacy v8.0 Deluxe Edition Software output. 
 
11.3.5. ACM 71 family 
With very limited information on names, estimated date of birth and places of residence of the 
proband, his parents and grandparents provided by the genetic counsellor we started tracing the 
ancestral lines of this family. The names of this family were recorded with incorrect spellings 
as it was translated from English to Afrikaans and key family histories such as places of birth 
were unknown. We determined that the proband (ACM 71.1), his mother (ACM71.5) and 
maternal grandparents resided in the Western Cape region. With this information we started 
using all the available information (per individual) in the local repositories on this family 
(section 10.16 on genealogical resources). 
Guided by the fact that the genotypes indicated that the PKP2 c.1162C>T mutation was 
inherited via the maternal line; we extended both the maternal and paternal lines of ACM71.5 
(Figure 17G). This family is of mixed ancestry and we had to employ alternative methods of 
tracing after the conventional way used for the other families failed to yield results.  The period 
under investigation included Apartheid government periods where records were separated by 
racial groupings and often some racial groups had poorly recorded and archived records. Some 
records in the Western Cape Archives of mixed ancestry individuals indexed did not have first 
names.  After searching all the indexes of towns of interest and their neighboring towns, other 
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regional registers were added and referenced which could randomly contain the baptismal 
record of interest.  Here we finally found the correct individual but the English name did not 
match the family’s interview details provided. Additionally, the other alternatives had the exact 
names from the interviews and the same place of baptism but not the same dates of birth. This 
led to the researcher first searching for ACM 71.5 name from the children’s birth records and 
requesting the research nurse to follow up with the family for further information in order to 
eliminate the erroneous records.  
The correct baptismal record of ACM 71.5 was found and her parents traced but the period and 
places they were married and born did not have records at the Western Cape Archives, as they 
were remote farming communities still with the mission churches. The SAGs and SAFs were 
searched and NGK Stellenbosch archives checked but no new information was found.  The 
respective Bredasdorp and Caledon repositories lacked any baptismal or marriage records of 
the proband’s maternal grandparents and the other repositories contacted including the 
Department of Home Affairs were not keen to assist, especially for research purposes as some 
of the records fall under the 100 year ban and are a conflict of interest with their security policy 
and adherence to the way they use the PAIA Act.  
This family search did not proceed any further than 1914, but we determined that the paternal 
line of ACM 71.5 was Afrikaner. An experienced researcher in mixed ancestry research in the 
Western Cape was consulted and it was suggested that based on the mother’s surname and 
other researched surname holders in the region, she is of African descent; we were unable to 
determine if she was of mixed ancestry.  
We managed to trace the family back by three generations to the early 20th century. This family 
search generated 12 individuals, no South African progenitors and no clear South African 
founding couples.  
We entered all the data into Legacy 8.0 deluxe edition, the data were analyzed manually and 





Figure 24: All relatives genealogically traced of ACM 71.1 in a tabular report.  
* As per Legacy v8.0 Deluxe Edition Software output. 
 
11.3.6. ACM 8 family 
This family was included during the last phase of the write-up. It has two root individuals due 
to the homozygous PKP2 c.1162C>T mutations found in both children (Figure 17B). We 
confirmed via Sanger sequencing that each parent carries a heterozygous mutation in PKP2. 
With very limited information on names, estimated dates of birth and places of residence of the 
proband (ACM 8.3) and her parents (provided by the genetic counsellor) we started tracing 
both the lines of this family. We determined that the proband and the parents resided in the 
Western Cape region. With this information we started using all the available information (per 
individual) in the local repositories on this family (section 10.16 on genealogical resources). 
We completed the name validation phase, searching their town of residence and neighboring 
towns. With the locally available resources, we reached the 1800s for most of the lines, until 
we found a database source of the SAGs; which includes the paternal lines of ACM 8.3 (with 
nearly 34000 individuals to search), including their non-South African progenitors. The 





11.3.7. ACM 57 family 
This family was included during the last month of the write-up. With very limited information 
pertaining to names, estimated dates of birth and places of residence of the probands and her 
parents (provided by the genetic counsellor) we started tracing the lines of this family. The 
names of this family were recorded with various spellings on the typed and hand written 
pedigrees. Key family histories such as places of birth were unknown. We determined that the 
proband (ACM 57.1) and the parents resided in the Western Cape region. With this information 
we started using all the available information (per individual) in the local repositories on this 
family (section 10.16 on genealogical resources). 
As we had no information of the nuclear family of the proband we begun tracing the maternal 
and paternal lines of the proband (Figure 17F). We are still in the name validation phase, 
searching their town of residence and neighboring towns. This was a recent finding and 
genealogical tracing still has to be done on this family. 
 
11.4 Combined genealogical analysis 
In order to determine the common South African founder couple we combined all genealogical 
data for the four completed families. 
During the completion of the largest two families (ACM 38 and ACM 19), there were 116 
couples which filtered down to 10 candidate South African founder couples (with the help of 
the ACM 5 family) that underwent further analyses. After the ACM 12 family was added to 
the analysis there were five candidate South African founder couples. The ACM 71 family 
did not progress past the 1900s as we were hampered by the fact that the family could not be 
linked back to any other family tree without finding the proband’s maternal great-
grandparents. The ACM 8 and 57 families were a recent finding and completion of the 




During the genetic screening phase of this study we observed the PKP2 c.1162C>T mutation 
in 30 individuals in 7 families. Where possible, all probands and at risk family members were 
clinically phenotyped and screened for the PKP2 c.1162C>T mutation.  
Most individuals carrying the mutation showed symptoms and signs of moderate to severe 
ARVC. All cases were classified as ‘definite’ cases according to the 2010 ARVC Task Force 
criteria. Our results also showed that not all c.1162C>T carriers were symptomatic at the time 
of phenotyping, which speaks to the incomplete penetrance of ARVC. When we compared the 
genotype to the phenotype for the individuals carrying the PKP2 c.1162C>T mutation, we 
observed two distinct groups: clinically affected individuals that displayed a mild to moderate 
ARVC phenotype and that usually presented at a more advanced age. Those with a more severe 
phenotype presented at a much younger age ARVC and their disease appeared to be triggered 
or exacerbated by a history of long-term endurance exercise.  
We identified four families, ACM 5, ACM 12, ACM 57 and ACM 71 that presented with a 
later age of onset and with a moderate form of ARVC.  The proband ACM 5.1, presented at 44 
years and was a professional athlete.  The proband ACM 12.1, presented at 45 years and was a 
marathon runner. Proband ACM 57.1, presented at 42 years and was also a marathon runner. 
Proband ACM 71.1, presented at 38 years and was a farm worker with a history of hypertension 
and smoking (inclusive of cannabis).  
Genetic screening of all four probands showed that they had only carried the pathogenic PKP2 
c.1162C>T mutation. We observed that most of the presenting/ affected family members had 
an athletic history and suspect that lifestyle, such as a long-term endurance exercise, aggravates 
or modifies the incomplete penetrance of ARVC, as seen in other ARVC studies (Pescatore et 
al., 2013, Pasquie et al., 2013). For the ACM71 proband, similar to other studies, the use of 
drugs and a history of hypertension may be thought to act as confounders (Sen-Chowdhry, 
2005). 
We identified three families, ACM 8, ACM 19 and ACM 38, who presented with an early age 
of onset and much more severe ARVC phenotype.  The ACM 8 family had two severely 
affected children; one whom died from an SCD at age 14 (ACM 8.4). Each of the siblings were 
homozygous for the PKP2 c.1162C>T mutation. The ACM 19 family had two severely affected 
siblings that were screened and diagnosed at 12 years and 14 years and required transplantation 
at ages 15 years and 17 years, respectively.  The ACM 38 family had three severely affected 
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children with the first child having sudden cardiac death at age 8 years, the proband presenting 
at pre-puberty and requiring a transplant at age 16 years while his brother was transplanted at 
age 8 years. Genetic screening of the two affected siblings of ACM 19 found a compound 
heterozygote in PKP2 (c.1162C>T and c.2197-2202 Ins/Del) (Watkins et al., 2009), resulting 
in a much more severe phenotype than the cases that had only inherited the c.1162C>T variant 
on its own.  Even though we have identified the c.1162C>T in the two affected siblings of the 
ACM 38 family (the proband ACM 38.3 and ACM 38.5), we hypothesize, due to (1) the 
severity and early age of onset and (2) the recombination in ACM 38.5, we can speculate that 
there is a second mutation, yet to be determined, linked to modifying the ARVC and PKP2 
c.1162C>T mutation seen in this family. Their mother (ACM 38.2) who carries the c.1162C>T 
mutation is well but has a history of miscarriages. We suspect the affected siblings may have 
inherited a pathogenic or modifier gene from their father (ACM 38.1) that exacerbates the 
ARVC phenotype seen in the affected siblings (Figure 17 E). We intend to screen this family 
using whole exome sequencing to test this hypothesis. 
We also observed that all families that carried the PKP2 c.1162C>T mutation were of 
Afrikaner decent and constructed a haplotype to indicate patterns of inheritance of the 
genotypes in the affected individuals.  We found that all individuals positive for the c.1162C>T 
mutation shared the same haplotype and were thus identical by descent from a common founder 
(Watkins et al., 2009). We used genealogy tracing to identify the five candidate common 
founder couples for the pathogenic PKP2 c.1162C>T mutation. 
According to the genealogical results, all the participants who were screened and who self-
identified as Afrikaners had genealogical evidence that strongly suggested their Afrikaner 
descent. Our data is consistent with the possibility that recurrent mutations are identical by 
descent in all five families. Five of the families carried the mutation from their parent without 
recombination and we assumed that ACM 12.1 and ACM57.1, with no relatives in the study 
yet, had the same disease-associated haplotype by descent (as confirmed by the laboratory 
screening). 
Most of the family trees had varying degrees of Dutch, German and French Huguenot ancestry. 
For example, ACM 12.1 is male and his family carried a common French Huguenot progenitor 
paternal lineage which contributing to his present day surname. As a result there were 
significantly more French Huguenot ancestors in his traced lines, in comparison to the others. 
However, he is still considered to be an Afrikaner because he has the genetic makeup of the 
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three ancestries that make up the Afrikaners by admixture, marrying Dutch, French and or 
German spouses. So he rightfully identified as an Afrikaner, and he self-identified by the 
correct descent. It was also observed that all five Afrikaner families had Western Cape 
Provincial roots which supports the South African history, whereby almost all progenitors of 
the Afrikaners stem from the old Cape Province located in the present day Western Cape 
Provincial area.  
Our results also showed that the ACM 38 family was the first and most completely traced 
family, from ACM 38.2 who presented 332 progenitor individuals and which were made up of 
116 progenitor couples. After the second family, ACM 19, was traced, through the paternal 
line, presenting a number of progenitors and progenitor couples; we manually made a common 
candidate progenitor couple list (from the Legacy Fan diagrams and Ancestor diagrams; not 
presented because they contain names, surnames, DOB and other confidential details) to 
narrow down the search to common candidate progenitor couples. Afterwards, we included the 
third most complete family, the ACM 5 family (through ACM5.1) and we observed 10 shared 
common candidate progenitors in the fourth family. ACM 12 further narrowed it down to five 
common candidate founder couples.  The fifth and final family, ACM 71, could not be linked 
back to the other four trees due to missing data or records. Without finding the baptismal 
records of the maternal great-grandparents, we encountered an impasse and could not proceed 
with the elimination process. 
Our study consisted of mostly white Afrikaners, except one mixed ancestry family classified 
as colored and Afrikaner (ACM 71), which is consistent with the international literature also 
pointing to the PKP2 c.1162C>T mutation being of European descent in four other 
international ARVC studies (Table 1). The international literature corroborates our finding that 
the PKP2 c.1162C>T founder mutation segregates with European Ancestry in South Africa. 
We also observed that Figures 20-23 show a counterintuitive phenomenon where the ancestors 
increase up till the 1800s but one observes a significantly diminished total number of 
individuals after the 1800s. This is due to four contributing factors, all mimicked by the 
diamond theory of ancestors (Appendix 7B): (1) the 100 year ban limiting the records we could 
access and add to our Legacy database; (2) the tracing method used i.e. it commenced with 
mostly currently living individuals, hence, those that had provided consent were entered in the 
20th century cohort and their deceased direct ancestors (exclusive of siblings) were entered, to 
avoid violating relatives privacy and the consent; (3) the recurrent/ duplicated ancestors or 
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names in a single family due to consanguineous marriages, high infant mortality, or renaming 
practices (Appendix 8.2.e), which were present in all four families independently and (4) the 
large number of children born in certain generations (1600s to 1800s) and high death rates 
(although the children’s records are well documented and were entered into the database in 
certain generations).  
During the course of this study, we also observed other known Afrikaner founders from other 
diseases in our family trees, which could be further filtered out by further data collected and 
more families hence, this small sample size (<10 probands) could not provide conclusive 
findings for the segregation of only the PKP2 c.1162C>T mutation (the hypothesis) in a 
homogenous population group, without increasing the sample size. Further, increasing the 
sample size, increases the ‘unrelated’ proband data set (increasing variation in the homogenous 
group), making the study statistically significant and powerful. 
After tracing all the families and eliminating  uncommon couples, we found the five different 
progenitor couples in South Africa (all of Afrikaner descent) that were linked to all four traced 
trees. However, we do not have sufficient proband families to identify a single founder or 
founding couple. Our observations propose that Geldenhuys’ (2014) observations were correct 
and that a total of 10 probands may be needed to find only one common couple or ancestor. 




13. Study Limitations  
This study was too small to draw a definitive genealogical conclusion (further explained in 
Appendix 10). This was due to the logistics related to the difficulty in recruiting participants 
nationwide namely, poor public awareness and the lack of standardized phenotyping. The 
researcher also encountered genealogical data collection issues such as (1) the 100 year ban 
associated with the PAIA policy; (2) the unfavorable position the  Department of Home Affairs 
has to take to unrelated data collectors of private records, including researchers, in order to 
keep the people’s records safe from misuse ; and (3) the loss or destruction of the historical 
documents of some people and communities (often slave, adopted or illegitimate progeny) 
through time (Myres et al., 2014). Finally, the researcher did not have enough time and 
resources to visit all the places required to collect data, outside a 100km radius from Cape 




14. Conclusion  
In this study, we searched for a common founder for the pathogenic PKP2 c.1162C>T mutation 
in ARVC families of Afrikaner decent in South Africa. Our probands were recruited from the 
ARVC Registry of South Africa and after phenotypic and genetic profiling, the families were 
extended.  
During the course of this study, when we correlated the genotype with the phenotype of the 
families we saw the families grouping into two distinct phenotype categories: moderate (later 
onset) and severe (early onset). Our phenotyping results showed that family ACM 5, ACM 12, 
ACM 57 and 71 had moderate (late onset) phenotypes, and ACM 19 and ACM 38 had severe 
(early onset) ARVC cases. 
Genetic screening indicated that 30 out of the 46 family members were positive for the PKP2 
c.1162C>T mutation and that all mutation positive individuals shared a common haplotype.  
Genealogical tracing revealed that (1) a single Afrikaner individual descends from hundreds of 
South African Afrikaner progenitor lines, (2) that relatives have lines in common; often termed 
as duplicate/shared ancestors, and (3) most of these Afrikaners progenitor lines can chiefly be 
classified as Dutch, French Huguenot or German. We also realized that homogenous 
populations may not produce a clear founder with less than ten ‘unrelated’ probands families, 
as they have many lines in common. Hence, we may need two additional apparently ‘unrelated’ 
probands to help with less common line elimination, in order to find one common founder or 
a common founding couple. 
The preliminary genealogical evidence generated from this study suggests that the PKP2 
c.1162C>T mutation segregates in Afrikaners exclusively and at a higher frequency due to a 
founder effect. The preliminary genealogical evidence is consistent with the hypothesis that 
PKP2 c.1162C>T is a founder mutation and descendants of the candidate common founders 






We have identified seven probands with eight family lineages that carry the PKP2 c.1162C>T 
mutation. Intensive genealogical analysis of 5 of these families has identified five candidate 
common founder couples for the PKP2 c.1162C>T founder mutation in Afrikaner families with 
ARVC. Additional work on the existing families is required to further reduce the number of 
candidate founder families. It is likely that the recruitment of at least two new cases carrying 
the recurrent mutation will be needed to conclusively identify the founder couple. We plan to 
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Appendix 1: ARVC Task Force Criteria.  
I. Global or regional dysfunction and structural alterations 
 
By 2D echocardiogram: 
Regional RV akinesia, dyskinesia, or aneurysm 
and 1 of the following (end diastole): 
PLAX RVOT ≥32 mm (corrected for body size [PLAX/BSA] ≥19 
mm/m2) 
PSAX RVOT ≥36 mm (corrected for body size [PSAX/BSA] ≥21 
mm/m2) 
or fractional area change ≤33% 
 
By MRI: 
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction 
and 1 of the following: 
Ratio of RV end-diastolic volume to BSA ≥110 ml/m2 (male) or ≥100 
ml/m2 (female) 
or RV ejection fraction ≤40% 
 
By RV angiography: 
Regional RV akinesia, dyskinesia, or aneurysm 
 
By 2D echocardiogram: 
Regional RV akinesia or dyskinesia 
and 1 of the following (end diastole): 
PLAX RVOT ≥29 to  <32 mm (corrected for body size [PLAX/BSA] 
≥16 to <19 mm/m2) 
PSAX RVOT ≥32 to <36 mm (corrected for body size [PSAX/BSA] 
≥18 to <21 mm/m2) 
or fractional area change >33% to ≤40% 
 
By MRI: 
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction 
and 1 of the following: 
Ratio of RV end-diastolic volume to BSA ≥100 to <110 ml/m2 (male) or 
≥90 to <100 ml/m2 (female) 
or RV ejection fraction >40% to ≤45% 
II. Tissue characterisation of wall 
 
Residual myocytes <60% by morphometric analysis (or <50% if 
estimated), with fibrous replacement of the RV free wall myocardium in 
≥1 sample, with or without fatty replacement of tissue on 
endomyocardial biopsy 
 
Residual myocytes 60% to 75% by morphometric analysis (or 50% to 
65% if estimated), with fibrous replacement of the RV free wall 
myocardium in ≥1 sample, with or without fatty replacement of tissue 
on endomyocardial biopsy 
III. Repolarisation abnormalities 
 
Inverted T waves in right precordial leads (V1, V2, and V3) or beyond 
in individuals >14 years of age (in the absence of complete right bundle-
branch block QRS ≥120 ms) 
 
Inverted T waves in leads V1 and V2 in individuals >14 years of age (in 
the absence of complete right bundle-branch block) or in V4, V5, or V6 
Inverted T waves in leads V1, V2, V3, and V4 in individuals >14 years 
of age in the presence of complete right bundle-branch block 
IV. Depolarisation/conduction abnormalities 
 
Epsilon wave (reproducible low-amplitude signals between end of QRS 
complex to onset of the T wave) in the right precordial leads (V1 to V3) 
 
Late potentials by SAECG in ≥1 of 3 parameters in the absence of a 
QRS duration of ≥110 ms on the standard ECG 
Filtered QRS duration (fQRS) ≥114 ms 
Duration of terminal QRS <40 mV (low-amplitude signal duration) ≥38 
ms 
Root-mean-square voltage of terminal 40 ms ≤20 mV 
Terminal activation duration of QRS ≥55 ms measured from the nadir of 
the S wave to the end of the QRS, including R0, in V1, V2, or V3, in the 
absence of complete right bundle-branch block 
V. Arrhythmias 
 
Nonsustained or sustained ventricular tachycardia of left bundle-branch 
morphology with superior axis (negative or indeterminate QRS in leads 
II, III, and aVF and positive in lead aVL) 
 
Nonsustained or sustained ventricular tachycardia of RV outflow 
configuration, left bundle-branch block morphology with inferior axis 
(positive QRS in leads II, III, and aVF and negative in lead aVL) or of 
unknown axis 
 >500 ventricular extrasystoles per 24 hours (Holter) 
VI. Family history 
 
ARVC/D confirmed in a first-degree relative who meets current Task 
Force criteria 
ARVC/D confirmed pathologically at autopsy or surgery in a first-
degree relative 
Identification of a pathogenic mutation categorised as associated or 
probably associated with ARVC/D in the patient under evaluation 
 
History of ARVC/D in a first-degree relative in whom it is not possible 
or practical to determine whether the family member meets current Task 
Force criteria 
Premature sudden death (<35 years of age) due to suspected ARVC/D in 
a first-degree relative 
ARVC/D confirmed pathologically or by current Task Force Criteria in 
second-degree relative 
 RV – Right Ventricle; PLAX – Parasternal Long Axis; RVOT – Right Ventricular Outflow Tract; PSAX – Parasternal Short Axis; BSA – body 
surface area;  MRI – Magnetic Resonance Imaging; SAECG – Signal-averaged electrocardiogram; ECG – Electrocardiogram; aVR – 
Augmented ventricular right; aVL – Augmented ventricular left; ARVC/D – Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia 




Appendix 2: Informed consent form and Request for Molecular Studies (DNA) 
 






























































Appendix 3: Template Death notice form and Archive requisition forms 
 





B) Requisition forms from the Western Cape Archives (English version). Must be signed 






Appendix 4: Diagrammatic Representation of Research outline 
 
 
Footnote: The ‘Phenotype’ indicates the participants clinically screened and classified to be affected by ARVC. They are further genetically 
screened and satisfy the relevant genotyping diagnostic criteria for the 3 microsatellite markers, M1, D12S1692 and M2, and the 3 exonic 
regions of interest, PKP2 Exon 4 and 11; and pedigrees are extended for genealogical tracing, used to track the founder. See more in 



















Appendix 6: Sequencing Reaction and Analysis Protocol Reaction  
 
Table 18: EXOSAP Reagents Mix. 
 
Table 19: EXOSAP PCR Conditions.  
 
Table 20: Big Dye Terminator Sequencing Reaction Mix. 
Table 21: Big Dye Terminator Sequencing Reaction Conditions.  
  
Reagent  Volume per reaction 
Exonuclease I 0.1 µl 
SAP (Shrimp Alkaline Phosphatase) 1 µl 
HRM Product 5 µl 
Final Reaction Volume (made up to 20 µl with dH2O) 20 µl 
CONDITION TEMPERATURE & TIME 
Incubation 37°C – 1 hour 
Deactivation 75°C – 15 minutes  
Cooling (Optional) 4°C – 30 minutes 
Reagent  Volume per reaction 
Forward Primer  0.5 µl 
Termination Buffer  2 µl 
Sequencing Buffer 0.1 µl 
EXOSAP HRM Product  3 µl 
Final Reaction Volume (made up to 20 µl with dH2O) 20 µl 
CONDITION TEMPERATURE & TIME 




96°C - 30 seconds 
50°C - 15 seconds                     50 cycles 
60°C - 4 minutes 
Cooling (Optional) 4°C - 30 minutes 
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 DNA Sequencing Analysis 
After you get the data from Stellenbosch, open the file and the follow these steps: 
1) In your annotation document, select your amplicon from the start of fwd primer to the 
end of rev primer and copy this to a new word document.  
2) Remove all spaces and “^” from the sequence as well as all numbers and rs numbers. 
(The whole sequence should be just one word). 
3) Then copy this sequence to note pad and save it in the same folder as the sequencing 
file. 
4) Open the chromatogram using the BioEdit Sequence Alignment Editor. Then open 
the window called “DNA Sequence Form” and click on “File” on the top left of the 
window. 
5) Then scroll to import and import your note pad file on the DNA sequence. 
6) Then select both (your file and notepad seq) and on top click on “Accessory 
Application” where you will select ClustalW multiple alignment. 
7) Then click on run “ClustalW”. You will get another window which will have both 
your sequences aligned on each other.  
8) Click on “shade identities” (icon) to color the sequences so that only changes will be 
left uncolored, this makes it easy for viewing. 
9) In the chromatogram, start looking for changes and find these positions in the 
annotation file. 
10) Open “ensembl” (http://www.ensembl.org/index.html) and select “human” and your 
gene of interest. Once that opens, select the transcript from the list of transcripts. Once 
you do that, on the left hand pane, you will see option to get cDNA of your gene.. 
11) In the cDNA sequence, find the change that you see in the chromatogram. Then 
calculate the cDNA nomenclature (middle line) and name it as c.(number)original 
base>new base and for the protein change p.(original aa)(position) (new aa). 
12) Report rs number (if there is one), there may also be a link to the dbSNP 
(http://www.ncbi.nlm.nih.gov/projects/SNP/)database next to the rs number 
explanation. 
13) If there is not rs number reported in ensemble (http://www.ensembl.org/index.html), 
check 1000genomes (http://browser.1000genomes.org/index.html), exome variant 
server (http://evs.gs.washington.edu/EVS/)and exac database 
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(http://exac.broadinstitute.org/) based on the position of amino acid change or cDNA 
position.  
For your convenience, the base changes in the chromatogram are given below: 
R- A, G 
Y- C, T 
M- A, C 
K- G, T 
S- C, G 
W- A, T 
H- A, C, T 
B- C, G, T 
V- A, C, G 
D- A, G, T 






Appendix 7: The two main theories of doubling ancestors 














In this theory the number of ancestors double each generation. It cannot represent the rest of the generations if a 
population has a higher frequency of homogeneity and so following is the number of theoretical ancestors in 
each generation, starting at Generation 12 where the figure above leaves off. Depending on the population 
group, mostly some population start with a few founding members and then grow, so from Geldenhuys’ (2014) 
work in medical genealogy in Afrikaners, often their ancestors begin to mimic the diamond model below (from 
the 10th generation). 
Gen. 12: 2048 
Gen. 13: 4096 
Gen. 14: 8192 
Gen. 15: 16384 





B. Diamond Theory of Ancestors 
In this theory the pyramid begins to narrow beyond the 10th generation; with x representing the number of 
individuals in each generation. However, in reality, several ancestors will be repeated in Afrikaner families, so 


















Adapted from: http://www.olivetreegenealogy.com/misc/ancestors.shtml   
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Appendix 8: South African Genealogical Tracing Protocol 
 
Standard Operating Procedure (SOP) for genetic Genealogy:  
1. Resources and records available for South African Genealogical Research 
a) Databases; such as  
(i) FamilySearch.org: This is an online database/platform provided by a genealogy organization 
operated by The Church of Jesus Christ of Latter-day Saints. It was previously known as the 
Genealogical Society of Utah (or "GSU") (established 1894) and is the largest genealogy 
organization in the world.  
(ii) NAAIRS (National Automated Archival Information Retrieval System): This is an online 
database/platform provided by the Department of Arts and Culture, which helps users of 
archives to identify and locate archival material in SA. NAAIRS contains only information 
about archival material, and not the actual texts of the documents. The texts are collected from 
the respective archives; under the references gathered from NAAIRS. 
b) Types of Records Available (restricted by 100 year ban PAIA (for birth records) and 20 year 
ban (for marriages and death records); (for further details see: Section 10.14 South African 
Public Records and Archival Considerations)): 
(i) Certificates (if first degree relative of person of interest; from the Department of Home 
Affairs) 
(ii) Baptisms (from church of baptism; often have a central archival repository) 
(iii) Marriages (from church of marriage; often have a central archival repository) 
(iv) Deaths and Burials (first search online, if not online; locate or visit cemetery of burial)  
(v) Death Notices (Accessing death notices attached to estate files are dependent on province; 
for example, in the Western Cape (WC): deaths up till 1979 are in the WC National Archive 
(records up till 1996 are in transit to the WC National Archives), deaths after 1996 are in the 
Vault Section of the Master’s Office, and deaths after 2008 consult WC Master of the High 
Court). 
(vi) Divorce (often referenced in NAAIRS database) 
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(vii) Wills (often attached with death notices, in the estate files or include title deeds, which 
can provide inheritance information of properties such as land property, homes or farms; which 
can be accessed from the local deeds office for a fee (Source: 
https://www.westerncape.gov.za/service/title-deeds-proof-property-ownership) 
(viii) Inventories 
(ix) Passenger Lists (often in the archives private collections, museums or transcribed into 
books) 
(x) Monumental Inscriptions  
(xi) Family Bibles (often at GISA) 
(xii) Oral History (Often given by informant or reported in media) 
(xiii) Church Minute Books 
(xiv) Military Records (only available from the military museums and repositories) 
(xv) Newspapers (often report personal details and orbituaries) 
(xvi) Publications  
(xvii) Research Assistance 
(xviii) Professional Researchers 
(xix) Online Guides and Resources  
(xx) Reference Books and Published genealogical tables 
(xxi) South African Genealogical Societies  
(xxii) Starting dates for South African Church Registers (often in church periodicals or 
encyclopaedia of SA) 







2. Preparation steps: 
a) Genetically test family of interest to discover eldest probands(s)/progenitor of disease 
b) i) Draw family pedigree of all the affected, ii) add patient interview details (including 
parent, grandparents and further generations) and iii) provide dates and places of birth, 
christening, marriage and death. 
c) In order to get a family search started for research purposes, establish whether or not 
the family has been researched before. Hence, read the 17 volumes of the SAGs (South 
African Genealogies) or 34 volumes of SAFs (South African Family Registers). 
d) In order to read the South African literature, one must familiarize with:  
i) the Pama/De Villiers System (the South African gold standard for family/ 
genealogical research. 
For example: In this system the genealogical number of the South African 
Stamouer/progenitor is “a”, and his children are numbered chronologically 
“b1”, “b2”, “b3” etc.; his grandchildren are the ‘c” generation, great 
grandchildren “d” and so on. (e.g. b1c3d5e2f5g8 etc.);  
ii) some Afrikaans and Dutch terms (suggested to use Google Translate, until you 
get the hang of things);  
iii) the Abbreviations and Symbols used in South African Genealogy. 
For example: 
1. *Born/Geboorte 
2. ≈ Christened or Bapt./Doop 
3. † Died/Sterfte 
4. Ω Buried/Graf of begrafnis 
5. ω Cremated/Veras 
6. x Marriage/Huwelik 
7. xx Second Marriage, etc/Tweede Huwelik 
8. ÷ Divorced/Egskeiding 
9. s.o./s.v. Son of/Seun van 
10. d.o./d.v. Daughter of/Dogter van 
11. wed Widow/ Weduwee 
12. wew Widower/Wewenaar 
13. ca About Date (Circa)/Ongeveer datum 
14. ? Estimated Date/Geskatte datum 
15. ≡ Calculated date/Berekende datum 
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16. < Before date/Voor datum 
17.  ca.After date/Na Datum 
18. / Between dates/Tussen Datums 
19. NN Name Unknown/Van onbekend 
20. Pn Given names unknown/ Voorname onbekend 
21. sp Without descendants/Sonder nasate (sine prole) 
22. [ ] Related by marriage/Aangetroudes 
23. {Title of person/Titel van person 
24.  a.Arrival in South Africa/Aankoms in Suid Afrika 
 
e) Learn traditional naming patterns for first names: 
Afrikaans families’ children often named according to European tradition, including 
the Netherlands and Germany. This tradition was less so in England. It seems to be 
most common from about the mid 1700’s to the first part of the 20th Century. 
 
For example: 
The first Son was named after the Father’s father 
The second Son was named after the Mother’s father 
The third Son was named after the Father 
The fourth Son was named after the Father’s eldest brother 
The fifth Son was named after the Mother’s eldest brother 
The first Daughter was named after the Mother’s mother 
The second Daughter was named after the Father’s mother 
The third Daughter was named after the Mother 
The fourth Daughter was named after the Mother’s eldest sister 
The fifth Daughter was named after the Father’s eldest sister 
 
Subsequent children were named following the same pattern, being named after the 
next eldest sibling of the father and mother. 
This system can be very useful genealogically. If there is a break in the pattern or the 
names appear to be out of order, it could indicate that a child has died young. The names 
were not usually used more than once (see Note below), but the system can result in 
children having the same name, e.g. if the child is the third child, and the father is the 




Note - if a child died, the name was usually used again, particularly in Afrikaans 
families and commonly in English families. It was not the name of the dead child that 
was being re-used but the name of the grandfather or grandmother, etc that was being 
given again. The system is by no mean invariable, even amongst Afrikaner families. 
f) Create or photocopy template documents to copy out data from archived repositories 
and/ or places where electronic devices such as mobile phones, tablets and cameras are 
restricted/prohibited. 
g) Copy spellings as is.  
h) Keep a notepad to keep track of the search. Also, make additional notes and highlight 
the multiple ways names, surnames and places can be spelt over time and dependent on 
the scribe of the information .e.g. Stephen (by an English assigned authority for relevant 
records) and Stephanus (by an Afrikaans assigned authority for relevant records). Or 
.e.g. variations in spelling for Edmond to Edmund or, etc. Or simply a spelling error 
.e.g. Petronella spelt as Petronela– in databases such as NAAIRS or family search.org. 
NB: Before confirming it is the same person, at least 2 other details should match the 
initial finding such as DOB and place of birth and variations in the name and surname; 
however, it is advised matched to the SAGs/SAFs lists or   family bibles. 
i) Get maps and encyclopaedias (at least one old and one new version, of each or find a 
repository with them) and other genealogical journals and readings to discover the name 
changes of old or new places; depending on the queries.   
j) Find out procedures for each individual repository; before visiting it. NB: There are 
often periodical changes in governmental repositories; as laws and policies change. 
Stay up-to-date with the changes and fill in the relevant paperwork and produce the 
relevant documentation required; in order to gain access to the information needed. 






3. Data Collection Steps:  
a) From pedigree and patient interview information obtain the eldest proband.  
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b) Extract (per individual): 
 
Detail Description 
Name(s) and Surname (if female: maiden and 
married or if adopted: adoption names and 
surnames (before and after)). 
 
Date of Birth (DOB) *DD/MM/YYYY
, place 
Date of Baptism ≈ DD/MM/YYYY, place 
Name of Parents and 
DOB/Baptism/Marriage/Death 
Father (Full names) x Mother (Full 
names, with maiden surname) 
Date of Marriage X DD/MM/YYYY, place 
Name(s) and Surname(s) of Spouse  
Name(s) and Surname(s) of Spouse’s parent’s  
DOB/Baptism/Death of Spouse DD/MM/YYYY, place 
Name(s) and Surname(s) of Children and DOB/ 
Baptism/Death of Children 
 
Date of Death † DD/MM/YYYY, place 




c) Go to the individual’s record and begin extracting clues for missing data. Often number 
the people in a logical pattern.  
Depending on what details you found available, visit a relevant record or resource.  
For example,  
Searching for the Abraham’s wife because the pedigree has missing first names one 
start’s by looking for the marriage record or through the children’s birth records. 
i. Search SAGs and SAFs for Abraham’s family tree. 
ii. Search NAAIRS. 
iii. Search NGK repository. 
iv. Search FamilySearch.org 
v. Add information found for to missing fields. 
d) Enter into generational grid (attached page). 
e) Enter into Genealogical software (.e.g. Legacy 8.0 deluxe). 
f) Look into her parents. Search person by person; do not exclude paternal or maternal 
lineage; unless genetic testing suggests a logical reason for individual lineages to be 
excluded. Continue to fill it in until all lines are complete as far back as possible. 
g) Preferred tracing to reach 10-12 generations back; but depends on record completeness 
and when the first founder of a line entered SA. For example, some families entered in 
subsequent ships such as the French Huguenots (refer to relevant history periods such 
as; Section 7.5 The founder effect in Afrikaners). 
4. Data Analysis: 
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a) Print out family chart and manually search for individuals or couples in common in the 
first two completed family trees.  
b) Extend the other trees and begin to eliminate families absent in other family trees and/ 
or record those also found in other subsequent family lines.   
c) It is often useful to do a top-down approach after there are less than 5 common ancestors 
of couples found and link them from the children’s lineage. 
d) Report results and collect further historical evidence on the couple such as the context 
and how they entered South Africa and related family history.  
(Adapted and modified from: https://www.geni.com/projects/South-African-Genealogical-
Reference-Centre/7572 , Prof. Gerhard Geldenhuys and Western Cape Archives training 2016 


























Appendix 10: Explanations regarding the various study limitations  
 
A10.1 Recruitment and sample size 
This study did not have sufficient probands to be able to draw definitive conclusions. Genetic 
genealogical studies often require 10 or more families to produce a statistically significant and 
clear genealogically-evidence based conclusion; ideally, a single founding ancestor. 
A10.2 Phenotyping 
Unfortunately, we were not able to phenotype all, however, at least all probands from each 
family or at least one clinically affected family representative was screened according to the 
most recent ARVC TFC, when they were enrolled.   
A10.3 Language, culture and Afrikaner history 
Some records or hand written information/ data was lost in translation from foreign languages, 
and I was not familiar with Dutch, German and Afrikaans records. I used Google translate and 
initially, Afrikaans native speakers’ translations; until they were familiar with terms relevant 
for the research. Common Afrikaner knowledge, undocumented/ verbatim cultural and/or 
historical knowledge was not included in study as I am a scientist.  
A10.4 Genealogical data collection 
Unfortunately, we were not able to extend the ACM 71 family beyond three generations as 
their records were very limited and inaccessible. The gap in some of the records, especially 
from mixed ancestry and non-Caucasian lineages, were mainly due to the changeover in 
systems from the Apartheid legislation (1948), that institutionalized (in South Africa) a policy 
or system of segregation or discrimination on grounds of race. In order to protect person(s) or 
families (1948-1994; during the Apartheid rule) from being constrained and conditioned by 
one's designated "racial" group, many records of racial mixes were “lost”, unreported or 
inaccessible. Furthermore, some families that were classified as “white” from all walks of life 
up to leadership were “denying the colored mother”(Distiller and Samuelson 2005). It is though 
that some records are hidden privately and some destroyed or so poorly kept that was difficult 
to decipher. 
One example of this situation was that the birth record for the mother was in a repository that 
had records that were in a very poor state (pages were torn) and because they were hand written 
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it was difficult to confirm who the parents were. In other instance, the missing records  were 
due to (1) lack of coordination and organization of records or (2) simple rebellion to the NGK 
by the mission churches (due to ‘sins’ of the NGK under Apartheid legislation; such as 
providing the government the records used to keep track of families and racially reclassifying 
individuals, yearly).  This history of their internal feuds due to some underlying social, 
economic and political issues still lives on especially in small, farming areas. For a time some 
names were removed or records kept track of ‘free’ slaves and racial grouping. Hence, they 
were used by the Apartheid government to monitor and highly tax poor farm workers who were 
not classified as “white”. 
Secondly, the other limitation is the central repository for all national records, the Department 
of Home Affairs (DHA), does not assist researchers. However, they portray mixed messages 
on the procedures to be followed. Some time was wasted in the beginning waiting for a DHA 
response (at least 6 weeks). 
Also, record mis-referencing, different names and wrong names documented on various 
documents; caused a few tracing problems, often having to look for more documents to confirm 
or eliminate the case. An example of mis-referencing was, in the Western Cape Archives, the 
death notices are referenced by volume number as this repository has at least 27 km of files; 
alone, excluding what the Western Cape Master of the High court office (MOOC) vault and 
MOOC office have. A death notice in an estate file had a husband’s deceased name and 
reference in the Western Cape Archive. After requesting the file, with the mis-referenced 
reference entered into the Archival Requisition form (Appendix 3B), the box of files had 
another, unrelated person’s document at that reference. On querying this matter with the 
Principal Archivist, the error was attributed to typing error of the data capturer.  We searched 
by date of death, place of death and the surname and then name and the file was found; which 
matched the search.  
An example for different names that occurred during my search, a baptismal register of an 
Afrikaans child in his mother’s parish (the Methodist Church in Transvaal around 1875; 
because the mother was English) lead the child to be recorded with the three English versions 
of his first name and the rest of his records named after his Afrikaans version of the names 
(from marriage register, death notice, estate file and will). We had to trace his sibling and use 
the SAFs to confirm it was the same person. 
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Another example, with wrong names occurred with a Free State MHG Free State query, where 
the spouse of the deceased (Appendix 3A, Section 7b on the form) had the wrong name and 
surname of the pre-deceased spouse filled out by the current wife of the deceased. The reference 
was looked into by the researcher and the naming pattern had been thrown off by this error. 
The researcher had to find the marriage record of the couple and complete list of children with 
the pre-deceased and witnesses to confirm it was an error on the record and not the researcher’s 
mistake. Fortunately, the second spouse did not have any children. So all the baptismal records 
and marriage register contained the correct first spouse’s name and so did the estate files and 
will of the deceased; if he had children with the new spouse it may have been more difficult to 
follow naming patterns.  
Finally, time was a major limiting factor as we could have physically visited repositories 
outside of those within a 100km radius from Cape Town (inclusive of the deeper farming areas; 
which may still have ACM 71 family records). Also time limited the number of probands we 
had recruited and could in future, further expand the current families or possibly identified 
additional families with the PKP2 c.1162C>T mutation. 
 
 
 
 
